netFormulary
 Report : A-Z of formulary items 05/04/2020 02:18:49
[Back]
 
Section Name Details
02.06.02  
03.01.03  

Prescribe by brand name

05.03.05 Ribavirin 

Chronic hepatitis C in line with the recommendations in NICE TA 75, TA 106 and TA 200. Hepatitis C in children and young people 3-17 NICE TA 300

06.01.01.03 4SURE 
05.03.01 Abacavir Ziagen®

HIV infection only

05.03.01 Abacavir and Lamivudine Kivexa®

HIV infection only

05.03.01 Abacavir and Lamivudine and Zidovudine Trizivir®

HIV infection only

10.01.03 Abatacept 

Infusion and subcutaneous injection

08.01.05 Abemaciclib Verzenios®
08.01.05 Abemaciclib Verzenios®

NICE TA563: Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer

08.03.04.02 Abiraterone Zytiga®
04.10.01 Acamprosate Campral EC®

Maintaining abstinence in alcohol dependence - refer to shared care guidelines

06.01.02.03 Acarbose Glucobay®
09.06.04 Accrete D3® 

Tablets can be swallowed whole or broken in half

02.08.02 Acenocoumarol Sinthrome®
11.06 Acetazolamide Diamox®

Tablets

 

SR capsules

12.01.01 Acetic acid 2% spray Earcalm ®
20 Acetic Acid Solution 5% 
11.08.02 Acetylcholine Chloride Miochol-E®
18 Acetylcysteine 

Paracetamol overdose

20 ACETYLCYSTEINE  
11.08.01 Acetylcysteine 5% with Hypromellose 0.35% Ilube®
03.07 Acetylcysteine injection 

Administered via nebuliser as a mucolytic  - refer to PHT Drug Therapy Guideline 107.03

20 Acetylcysteine tablets 
05.03.02.01 Aciclovir 
05.03.02.01 Aciclovir 
13.10.03 Aciclovir 5% cream 

NHS England low value medication

A prescription for treatment of cold sores should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

 

11.03.03 Aciclovir eye ointment 3% Zovirax®

This product will be discontinued. GSK anticipate supplies to be available until June 2019.

A suitable alternative is ganciclovir eye gel

01.01.02 Acidex Advance® 

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

02.12 Acipimox Olbetam®

Restricted Item Information on restriction - Mixed dyslipidaemia unresponsive to statins and intolerant of fibrates

13.05.02 Acitretin Neotigason®
03.01.02 Aclidinium Eklira Genuair®

LAMA in multidose dry powder inhaler device. Refer to COPD guidelines

03.01.04 Aclidinium and formoterol inhaler Duaklir Genuair ®

LABA+LAMA. Refer to COPD guidelines

19.23 Actico 10cm x 6m 

Cohesive short stretch bandage for single use and adapted according to ankle circumference. can be worn for up to 7 day. Recommended in patients with an ABPI of > 0.8


10cm width for routine below knee leg ulcer bandaging.

19.23 Actico 12cm x 6m 

12cm Actico bandages are for use in patients with chronic oedema. 12 cm banadge should be applied to the thigh.

19.23 Actico 8cm x 6m 

8cm Actico bandages are for use in patients with chronic oedema. 8 cm banadge should be applied to the foot.

19.22 Acti-Glide Compression hosiery application system 

Supply of a single unit only

13.08.01 Actikerall® Fluorouracil 0.5%/ salicylic acid 10%
19.22 ActiLymph  Class 1 18-21mmHg

Light compression Hosiery for early mild chronic oedema with little leg distortion. suitable for chronic oedema, lymphoedema, lipoedema, prophylaxis, maintenence therapy and palliative use.


Available in Below knee and above knee. Wide or regular band. Closed toe and open toe. Various colours and sizes.

19.22 ActiLymph  Class 2 23-32mmHg

Medium compression hosiery for moderate to severe chronic oedema and lymphoedema where resistant oedema occurs and shape disfunction.


Available in Below knee and above knee. Wide or regular band. Closed toe and open toe. Various colours and sizes.

19.22 ActiLymph  Class 3 34-46mmHg

Provides strong compression and should be used for maintenance of severe chronic oedema and lymphoedema, where resistant oedema persists, history of recurring ulceration or where lymphatic damage is considerable and use of lower classes has proved ineffective.


Available in Below knee and above knee. Wide or regular band. Closed toe and open toe. Various colours and sizes.

19.22 Activa Leg Ulcer Hosiery Kit 1 stocking, 2 liners

Available as small, medium, large , XL, XXL. Useful for active ulceration to apply full compression for patients who can't tolerate bandaging. Assessing and measuring as per single hosiery product.

19.22 Activa Liner pack (3 liners) 

Liner pack available in all sizes, both open and closed toe.

19.22 Activa support compression hosiery Class 1 14-17mmHg

Light (mild) compression Hosiery


Available in Below knee and thigh length, closed toe and open toe. Various colours and sizes.

19.22 Activa support compression hosiery Class 2 18-24mmHg

Medium (moderate) compression hosiery


Available in Below knee and thigh length, closed toe and open toe. Various colours and sizes.

19.22 Activa support compression hosiery Class 3 25-35mmHg

Strong support compression hosiery for recurring leg ulceration and gross varices.


Available in Below knee and thigh length, closed toe and open toe. Various colours and sizes.

18 Activated charcoal 

Antidote for acute poisoning with various medicines/poisons

01.05.03 Adalimumab Humira® Imraldi® Amgevita®

Prescribe by brand name

Crohns Disease in line with NICE TA 187, moderately to severely active ulcerative colitis NICE TA 329

10.01.03 Adalimumab Imraldi ® Amgevita ® Humira ®
11.04.02 Adalimumab injection Imraldi ® Amgevita ® Humira®
13.05.03 Adalimumab injection Imraldi ® Amgevita ® Humira®
13.06.01 Adapalene Differin®
13.06.01 Adapalene / Benzoyl Peroxide Epiduo®
09.06.04 Adcal-D3 Dissolve® 

For patients requiring a soluble preparation


Calcium carbonate 1500mg equivalent to 600mg of elemental calcium, Colecalciferol 400iu equivalent to 10μg vitamin D

09.06.04 Adcal-D3® 

Note doses are different between chewable tablets and caplets

 

 

05.03.03.01 Adefovir Dipivoxil Hepsera®

Chronic hepatitis B in line with NICE TA 96

02.03.02 Adenosine 
08.02.02 Adoport® Tacrolimus

RED for Renal transplant patients

03.04.03 Adrenaline (epinephrine) 1 in 10,000 (dilute) 
03.04.03 Adrenaline (epinephrine) 1 in 1000 injection 
03.04.03 Adrenaline (epinephrine) injection 

Self-administered for anaphylaxis


Emerade, EpiPen, Jext


Prescribe by brand name.

02.07.03 Adrenaline / Epinephrine 1 in 10,000 (dilute) injection 
11.05 Adrenaline 0.1% preservative free  
08.02.02 Advagraf® Tacrolimus

RED for Renal transplant patients

03.01.05 AeroChamber Plus® 
08.01.05 Afatinib Giotrif®
11.08.02 Aflibercept Eylea®
04.03.04 Agomelatine Valdoxan®

Refer to mental health provider guidelines

20 Ajmaline injection 

Consultant cardiologist only for diagnosis of Brugada syndrome

13.11.01 Alcohol impregnated swabs Sterets
08.01.05 Alectinib Alecensa®

NICE TA536: Alectinib for untreated ALK-positive advanced non-small-cell lung cancer

06.06.02 Alendronic Acid Tablets 70mg
09.06.04 Alfacalcidol 
15.01.04.03 Alfentanil 
10.03.02 Algesal 

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

03.04.01 Alimemazine 

Only as an option for use in paediatric patients requiring sedation for procedures

02.12 Alirocumab Praluent®

Primary hypercholesterolaemia or mixed dyslipidaemia

13.05.01 Alitretinoin Toctino®

NOTE 10mg and 30mg capsules are the SAME PRICE (£411) per pack of 30 capsules.


Do not dispense 3 x 10mg capsules if a patient is on 30mg (standard) dose.

19.11 Allevyn Life 12.9cm x 12.9cm 

Hyper-absorbent. For use on high exudating wounds where a wear time 5 - 7 days is required.

19.11 Allevyn Life 15.4cm x 15.4cm 

Hyper-absorbent. For use on high exudating wounds where a wear time 5 - 7 days is required.

10.01.04 Allopurinol 
06.01.02.03 Alogliptin Vipidia▼®

First choice DPP-4 inhibitor for new initiations

09.06.05 Alpha Tocopheryl Acetate 
13.09 Alphosyl 2 in 1® shampoo Alcoholic coal tar extract 5%
07.01.01.01 Alprostadil Prostin VR®

Restricted Item Information on restriction - Neonatal unit only

07.04.05 Alprostadil Caverject

SLS endorsement required in primary care

 

Training on use must be given in secondary care

 

 

07.04.05 Alprostadil Viridal® Duo

Viridal Duo is used if Caverject is not available

07.04.05 Alprostadil 3mg/g cream Vitaros®

SLS endorsement required in primary care

02.10.02 Alteplase Actilyse®

For Pulmonary embolism and acute ischemic stroke.

11.99.99.99 Alteplase intravitreal injection 

Submacular haemorrhage - unlicensed

13.12 Aluminimum chloride hexahydrate Anhydrol Forte®

Aluminium chloride hexahydrate 20% in an alcoholic basis

NHS England low value medication

A prescription for high strength antiperspirants for the treatment of mild to moderate hyperhidrosis should not routinely be offered in primary care as the condition is appropriate for self-care

13.12 Aluminimum chloride hexahydrate  Driclor®

Aluminimum chloride hexahydrate 20% in an alcoholic basis

NHS England low value medication

A prescription for high strength antiperspirants for the treatment of mild to moderate hyperhidrosis should not routinely be offered in primary care as the condition is appropriate for self-care

09.05.02.02 Aluminium Hydroxide Alu-Cap®
01.01.01 Aluminium Only Preparations Alu-Cap®

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

04.09.01 Amantadine 

Includes capsules and syrup

05.01.04 Amikacin 

On microbiology advice only


100mg in 2ml injection

11.03.01 Amikacin 2.5% eye drops 

Unlicensed

02.02.03 Amiloride Hydrochloride 
03.01.03 Aminophylline Phyllocontin Continus®

Prescribe by brand name

03.01.03 Aminophylline injection 
02.03.02 Amiodarone 

Suspension 50mg in 5ml - unlicensed special (paediatrics only)

02.03.02 Amiodarone 
04.02.01 Amisulpride 
04.03.01 Amitriptyline 
04.07.03 Amitriptyline 
04.07.04.02 Amitriptyline 
02.06.02 Amlodipine 
05.01.01.03 Amoxicillin 
05.02 Amphotericin Fungizone®
05.02 Amphotericin AmBisome®
11.03.02 Amphotericin 0.15% 

Unlicensed - Ophthalmology only

09.01.04 Anagrelide Xagrid®
10.01.03 Anakinra Kineret®
08.03.04.01 Anastrozole 
12.03.01 Antacid with Oxetacaine 

unlicensedunlicensed - Refer to mouthcare guidelines

11.04.02 Antazoline 0.5% with xylometazoline 0.05% Otrivine-Antistin®

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

14.05.03 Anti-D (Rh0) Immunoglobulin 
08.02.02 Antithymocyte immunoglobulin (rabbit)  Thymoglobuline®
01.07.01 Anusol 

Includes ointment and suppositories

NHS England low value medicine

A prescription for treatment of haemorrhoids should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

01.07.02 Anusol-HC 

Includes ointment and suppositories

NHS England low value medicine

A prescription for treatment of haemorrhoids should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

02.08.02 Apixaban Eliquis®

VTE prophylaxis following elective hip and knee replacement (full course to be supplied by hospital)


Stroke prevention in non-valvular AF


DVT and PE treatment and secondary prevention

04.09.01 Apomorphine 

Consultant only - requires specialist initiation and supervision

11.08.02 Apraclonidine Iopidine®

Apraclonidine 0.5% eye drops - short-term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.


Apraclonidine 1% single dose - to control or prevent post surgical elevations in intraocular pressure that occur in patients after anterior segment laser surgery.

13.05.03 Apremilast Otezla®
04.06 Aprepitant Emend®

NHSE funded chemotherapy supportive drug 


PONV following bariatric surgery (off-license)

13.02.01 AproDerm Colloidal Oat Cream® 

Cost effective alternative to Aveeno cream

A2.01 Aptamil Pepti 1 and 2 
A2.01 Aptamil Pepti 1® 

Pepti 1 and 2 - for Cows Milk Protein Allergy

 

Extensively Hydrolysed Formula

 

First line agent

A2.01 Aptamil Pepti Junior® 

On the advice of secondary care only

 

Cows Milk Allergy and malabsorption

13.02.01 Aquamol® cream 

Can be used as a soap substitute

13.02.01 Aqueous Cream BP 

ZeroAQS is the lower cost alternative for prescribing in primary care.

01.06.03 Arachis Oil  
02.08.01 Argatroban Exembol®

Under advice of haematology only.

04.02.01 Aripiprazole 

First line if hyperprolactinaemia caused by other agents.  Schizophrenia in 15-17 year olds (second line) NICE TA 213.  Manic episodes in bipolar disorder in adolescents over 13 NICE TA 292

04.02.02 Aripiprazole Abilify Maintena®

Southern Health NHS FT and Solent NHS Trust psychiatrists only

08.01.05 Arsenic Trioxide Trisenox®
05.04.01 Artemether with lumefantrine Riamet®
20 Artesunate injection 

Falciparum malaria - refer to PHT Adult Antimicrobial Guide

15.02 Articaine Hydrochloride with Adrenaline Septanest®
12.03.05 AS Saliva Orthana® spray 
09.06.03 Ascorbic Acid Vitamin C

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

20 Asparaginase (Medac) Injection 10000 units 
04.07.01 Aspirin 

Mild to moderate pain

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

10.01.01 Aspirin 300mg

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

02.09 Aspirin (antiplatelet) 
05.03.01 Atazanavir sulfate and cobicistat Evotaz®

HIV infection only

02.04 Atenolol 
08.01.05 Atezolizumab  Tecentriq®
04.04 Atomoxetine Strattera®

Children - CAMHS initiation only

CAMHS Shared care agreement for Hampshire will be available on iDOCs

Adults - diagnosis and treatment initiation via Hampshire ADHD service (provided by Surrey and Borders Partnership NHSFT)

 

Awaiting shared care guidelines

02.12 Atorvastatin 

Prescribe generically, avoid chewable tablets

15.01.05 Atracurium Besilate 
19.01 Atrauman 10cm x 20cm  

May not be suitable for patients with sensitivities to conconut or its derivatives. Consider Tricotex for patients with coconut allergy.


 

19.01 Atrauman 20cm x 30cm  

May not be suitable for patients with sensitivities to conconut or its derivatives. Consider Tricotex for patients with coconut allergy.

19.01 Atrauman 5cm x 5cm  

May not be suitable for patients with sensitivities to conconut or its derivatives. Consider Tricotex for patients with coconut allergy.

19.01 Atrauman 7.5cm x 10cm  

May not be suitable for patients with sensitivities to conconut or its derivatives. Consider Tricotex for patients with coconut allergy.

15.01.03 Atropine  minijet®

Secondary Care only Except for Emergency use

18 Atropine 

Poisoning by organophosphorus or carbamate insecticides

11.05 Atropine 1% eye drops and unit dose eye drops 
15.01.03 Atropine sulfate 
07.04.05 Avanafil 

Second line for erectile dysfuntion


SLS endorsement required in primary care

13.02.01 Aveeno® cream 

Zeroveen is the lower cost alternative for prescribing in primary care.

08.01.05 Avelumab Bavencio®
06.01.06 Aviva Test Strip® 

Category 2

08.01.05 Axicabtagene ciloleucel YESCARTA®
08.01.05 Axitinib Inlyta®
A2.02.01.02 AYMES Shake 

First choice if food fortification is not sufficient


Use Aymes powder for care home patients and those with carers


USe Aymes complete for patients with no-one to make up the shake

08.01.03 Azacitidine Vidaza®
08.02.01 Azathioprine 
01.05.03 Azathioprine tablets 
01.05.03 Azathioprine tablets 
10.01.03 Azathioprine tablets 
13.05.03 Azathioprine tablets 

unlicensedunlicensed

13.06.01 Azelaic Acid Finacae®
12.02.01 Azelastine and fluticasone nasal spray Dymista®

Allergic Rhinitis, not first-line.


Only for patients requiring combination treatment with both agents to control symptoms.

12.02.01 Azelastine hydrochloride nasal spray 
05.01.05 Azithromycin 

Restricted prescribing as per Microguide or NICE prescribing guidance

05.01.05 Azithromycin 

Shared care for long-term prophylaxis in COPD and bronchiectasis only

11.03.01 Azithromycin Azyter®
05.01.02.03 Aztreonam Azactam®

On microbiology advice only

05.01.02.03 Aztreonam nebuliser solution Cayston®

For cystic fibrosis only in accordance with NHSE policy A01/P/b

04.07.03 Baclofen 
10.02.02 Baclofen 
11.08.02 Balanced salt solution 
13.02.01 Balneum® cream 

Contains 5% urea - for dry skin conditions

13.02.01 Balneum® Plus cream 

Contains 5% urea and lauromacrogols. For dry, scaling and itching skin

01.05.01 Balsalazide sodium capsules Colazide®

Only for patients intolerant of all mesalazine products.  Initiation by consultant gastroenterologist only

10.01.03 Baricitinib tablets Olumiant®
08.02.02 Basiliximab Simulect®
08.02.04 BCG bladder instillation OncoTICE®
08.02.04 BCG bladder instillation ImmuCyst®
14.04 BCG vaccine diagnostic agent 
14.04 BCG vaccine Intradermal 

For use in at risk groups only (newborn infants of parents from high risk areas and those resident in or originating from high incidence areas)


None of the local CCGs meet the criterion for a high incidence area.

06.01.01.03 BD Viva 
03.02 Beclometasone Kelhale®

Prescribe by BRAND name

Cost effective alternative to QVAR inhaler - only available as MDI

03.02 Beclometasone Qvar®

MDI / Autohaler / Easi-Breathe

 

Prescribe by BRAND NAME - Kelhale is a cost effective alternative for patients requiring a MDI

03.02 Beclometasone Clenil Modulite®

Prescribe by BRAND NAME - CFC-free beclometasone inhalers are NOT interchangeable

03.02 Beclometasone and formoterol Fostair®

MDI and NEXThaler


Asthma Step 3 BTS guidelines for adults over 18, COPD – refer to local guidelines

03.02 Beclometasone Clickhaler Asmabec

Dry powder

20 Beclometasone dipropionate 0.0025% w/w in WSP BP ointment 

Unlicensed special listed on BAD specials list 2018

12.02.01 Beclometasone dipropionate nasal spray 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

01.05.02 Beclometasone m/r tablets Clipper®

Mild to moderate ulcerative colitis in active phase - full course to be supplied by hospital

10.01.03 Belimumab Benlysta®
08.01.01 Bendamustine Levact®

For indications and criteria for CDF funding refer to CDF list.

02.02.01 Bendroflumethiazide 
04.02.01 Benperidol Anquil®

Psychiatry only

 

Note HIGH COST in primary care

03.04.02 Benralizumab Fasenra®
20 Benzbromarone 100mg tablets  

Gout - consultant rheumatologist only

20 Benzoin Tincture, Compound, BP 
13.06.01 Benzoyl Peroxide PanOxyl®

Aquagel (aqueous gel) 2.5%, 5%, 10%


Cream 5%


Gel 10%


Wash 10%

13.06.01 Benzoyl Peroxide 5% with Clindamycin 1% Duac® Once Daily
12.03.01 Benzydamine Difflam®

NHS England low value medicine

A prescription for treatment of acute sore throat should not be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

13.10.04 Benzyl Benzoate Application BP 25% 

Scabies - not first choice

05.01.01.01 Benzylpenicillin 
11.03.01 Benzylpenicillin  

Unlicensed special - Ophthalmology Only

04.06 Betahistine Dihydrochloride 

Meniere's disease

06.03.02 Betamethasone Betnesol®
06.03.02 Betamethasone 
13.04 Betamethasone 0.025% Betnovate-RD®
13.04 Betamethasone 0.05% with Salicylic Acid 3% Diprosalic®
13.04 Betamethasone 0.1% Betnovate®
13.04 Betamethasone 0.1% with Fucidic Acid 2% Fucibet®
12.01.01 Betamethasone 0.1% with Neomycin 0.5% ear drops Betnesol N®
11.04.01 Betamethasone 0.1% with Neomycin 0.5% eye drops Betnesol N®
12.02.03 Betamethasone 0.1% with neomycin 0.5% nasal drops 
12.01.01 Betamethasone ear drops 
11.04.01 Betamethasone eye drops 
11.04.01 Betamethasone eye ointment Betnesol®
12.02.01 Betamethasone nasal drops 
13.04 Betamethasone valerate medicated plaster Betesil®
11.06 Betaxolol Betoptic®
20 Bevacizumab intravitreal injection 

Only for neovascular eye conditions not covered by NICE recommendations.

02.12 Bezafibrate 

Prescribe generically

06.01.06 BG Star® 

Category 2

19.12 Biatain Silicone adhesive 10cm x 10cm 

A soft, absorbent polyurethane foam pad with a vapour-permeable film backing and a silicone adhesive border.

19.12 Biatain Silicone adhesive 12.5cm x 12.5cm 

A soft, absorbent polyurethane foam pad with a vapour-permeable film backing and a silicone adhesive border.

19.12 Biatain Silicone adhesive 15cm x 15cm 

A soft, absorbent polyurethane foam pad with a vapour-permeable film backing and a silicone adhesive border.

19.12 Biatain Silicone adhesive 7.5cm x 7.5cm 

A soft, absorbent polyurethane foam pad with a vapour-permeable film backing and a silicone adhesive border.

08.03.04.02 Bicalutamide 
05.03.01 Bictegravir 50mg emtricitabine 200mg tenofovir alafenamide 25mg Biktarvy

HIV infection only

NHSE clinical commissioning policy 170131P

11.06 Bimatoprost Lumigan®

Second line after latanoprost.

 

0.1mg per ml (100mcg per ml) available in 3ml bottles

 

0.3mg per ml (300mcg per ml) available in single dose containers only

 

 

11.06 Bimatoprost with Timolol Ganfort®
08.01.05 Binimetinib Mektovi ®
12.03.05 Biotene Oralbalance® gel 

ACBS

06.01.01.02 Biphasic Insulin Aspart NovoMix® 30
06.01.01.02 Biphasic Insulin Lispro Humalog® Mix

Mix 25 and Mix 50

06.01.01.02 Biphasic Isophane Insulin Hypurin® Porcine 30/70 Mix
06.01.01.02 Biphasic Isophane Insulin Humulin® M3
06.01.01.02 Biphasic Isophane Insulin Insuman® Comb

Comb 15 - 3ml cartridges


Comb 25 - 5ml vials, 3ml cartridges & Solostar pen


Comb 50 - 3ml cartridges

12.02.03 BIPP Gauze 
01.06.02 Bisacodyl 

Includes tablets and suppositories

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

01.03.03 Bismuth subsalicylate Pepto-Bismol®

Only for use in accordance with SCAN guideline

02.04 Bisoprolol 
09.05.01.02 Bisphosphonates 

See Chapter 6.6 or individual drugs : disodium pamidronate, zoledronic acid

02.08.01 Bivalirudin Angiox®
08.01.02 Bleomycin 
08.02.03 Blinatumomab Blincyto®
14.04 Boostrix-IPV 

Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)


For pregnant women at risk of whooping cough

08.01.05 Bortezomib Velcade®
08.01.05 Bosutinib Bosulif®
01.07.04 Botulinum toxin type A 

Anal fissure - approved off-licence indication

04.07.04.02 Botulinum Toxin Type A Botox®

Migraine prophylaxis

04.09.03 Botulinum Toxin Type A 

Refer to list of approved indications

14.04 Botulism antitoxin 

Specialist clinics only

08.01.05 Brentuximab vedotin Adcetris®
08.01.05 Brigatinib Alunbrig®
13.06 Brimonidine gel Mirvaso®
11.06 Brimonidine Tartrate generic
11.06 Brimonidine Tartrate 0.2% with Timolol 0.5% Combigan®
11.06 Brinzolamide generic

May be better tolerated than dorzolamide

11.06 Brinzolamide 1% with Timolol 0.5%  Azarga®
11.06 Brinzolamide 10mg/ml & brimonidine 2mg/ml Simbrinza®
04.08.01 Brivaracetam Briviact®

Consultant neurologist only to initiate for patients with refractory epilepsy and where other antiepileptics are contraindicated, ineffective or not tolerated.

 

Specialist to establish benefit and stabilise dose before request is made to GP to provide ongoing prescriptions.

 

 

13.05.03 Brodalumab Kyntheum®
11.08.02 Bromfenac Yellox®
04.09.01 Bromocriptine 
06.07.01 Bromocriptine 

Secondary Care initiated

01.05.02 Budesonide Entocort®

Full course to be supplied by the hospital.

03.02 Budesonide 

MDI / Turbohaler / nebuliser solution

01.05.02 Budesonide 2mg/dose rectal foam Budenofalk®

Second line option whilst Colifoam not available

01.05.02 Budesonide 3mg capsules Budenofalk®

When used for relapses of small bowel Crohn's disease - full course to be supplied by hospital.

 

Amber Initiated when prescribed for autoimmune hepatitis - course may be continued in primary care.

03.02 Budesonide and formoterol Symbicort®
03.02 Budesonide and formoterol DuoResp Spiromax®

Alternative to Symbicort for new initiations. Adults only (over 18). Prescribe by brand name

01.05.02 Budesonide m/r tablets Cortiment MMX®

To induce remission in mild to moderate active ulcerative colitis - full course to be supplied by hospital

02.02.02 Bumetanide 
15.02 Bupivacaine and adrenaline 

Bupivacaine 0.25% with adrenaline 1 in 200,000


Bupivacaine 0.5% with adrenaline 1 in 200,000

15.02 Bupivacaine hydrochloride 

Bupicvacaine 0.25% and 0.5%

15.02 Bupivacaine with fentanyl 

Bupivacaine 0.1% with fentanyl 2 micrograms per ml

04.07.02 Buprenorphine 

Moderate to severe pain

04.10.03 Buprenorphine 

Opioid dependence

Awaiting shared care guideline

04.10.03 Buprenorphine and Naloxone Suboxone®

Substance Misuse services only

04.07.02 Buprenorphine transdermal patch BuTrans®, Butec®

Moderate non-cancer pain requiring an opioid analgesic if other agents by the oral route are not suitable or not tolerated.  

 

Change patch every 7 days. 

 

Prescribe by brand name. In primary care the most cost effective brand is Butec

04.07.02 Buprenorphine transdermal patch Transtec® Bupeaze®

Moderate to severe chronic pain including cancer pain requiring an opioid analgesic where oral morphine is unsuitable or not tolerated.  Palliative care.    

 

Change patch every 4 days. 

 

Prescribe by brand name. In primary care the cost effective brand is Bupeaze

04.10.02 Bupropion Hydrochloride Zyban®

As part of smoking cessation programme

04.01.02 Buspirone Hydrochloride 

For use by Southern Health as per the anxiety treatment guidelines only

08.01.01 Busulfan 
03.04.03 C1 Esterase Inhibitor Berinert® Cinryze®

Acute Treatment or Short-term prophylaxis prior to planned procedures for Hereditary Angioedema and Acquired Angioedema in accordance with NHS England commissioning policy.


Prophylactic treatment of hereditary angioedema (HAE) types I and II in accordance with NHS England commissioning policy - specialist centres only (UHS)


 

08.01.05 Cabazitaxel Jevtana®
04.09.01 Cabergoline 
06.07.01 Cabergoline 
08.01.05 Cabozantinib Cometriq®

For treating medullary thyroid cancer

08.01.05 Cabozantinib Cabometyx®
03.05.01 Caffeine citrate solution 20mg/ml Peyona®

Neonatal unit only. Peyona can be used for intravenous infusion and oral administration.

13.03 Calamine 
09.06.04 Calceos® 

Calcium carbonate 1.25 g (calcium 500 mg), colecalciferol 10 micrograms (400 units) per tablet

09.05.01.01 Calcichew® 

Calcium carbonate 1.25 g (calcium 500 mg or Ca2+ 12.5 mmol) per tablet

09.06.04 Calcichew-D3® Forte 

Calcium carbonate 1.25 g (calcium 500 mg) colecalciferol 10 micrograms (400 units) per tablet 

13.05.02 Calcipotriol Dovonex®
13.05.02 Calcipotriol with betamethasone  Dovobet®

Gel can be used on the scalp and body

13.05.02 Calcipotriol with betamethasone  Enstilar®
06.06.01 Calcitonin (salmon) / Salcatonin 

Secondary Care only

09.06.04 Calcitriol 
13.05.02 Calcitriol ointment Silkis®

For flexures and vulval psoriasis

18 Calcium chloride injection 
09.05.02.02 Calcium Acetate Phosex®
09.06.04 Calcium and Ergocalciferol 
09.05.02.02 Calcium Carbonate Calcichew®
09.05.01.01 Calcium Chloride 
08.01 Calcium Folinate 

Folinic acid rescue. Adjunct to 5-fluorouracil.

18 Calcium folinate injection 

Methotrexate overdose

09.05.01.01 Calcium Gluconate 
18 Calcium gluconate gel 
18 Calcium gluconate injection 
08.01 Calcium Levofolinate 

Adjunct to 5-fluorouracil in colorectal cancer

09.05.02.02 Calcium Salts Osvaren®

Red for renal dialysis patients

09.05.01.01 Calcium syrup  Alliance

Paediatrics only on specialist advice. Contains calcium 2.55mmol in 5ml.


Alliance Calcium Syrup is a food supplement but it can be prescribed on FP10.

13.02.01 Calmurid® cream 

Contains 10% urea

06.01.02.03 Canagliflozin Invokana▼®
02.05.05.02 Candesartan 
02.09 Cangrelor 

Restricted Item Information on restriction - Only for patients undergoing primary PCI where oral administration of P2Y12 inhibitor is not possible.

04.08.01 Cannabidiol Epidyolex
10.02.02 Cannabis extract Sativex®

Hospital only agent until a shared care guideline is approved

 

Approved only for use as per NICE criteria

13.09 Capasal® 

Coal tar 1%, coconut oil 1%, salicyclic acid 0.5%

08.01.03 Capecitabine 
12.03.01 Caphosol® 

Prophylaxis and treatment of oral mucositis in patients with head and neck cancer receiving radiotherapy with or without chemotherapy

10.03.02 Capsaicin 0.025% cream Zacin

Adjunct for knee and hand OA

10.03.02 Capsaicin 0.075% cream Axsain

Option for localised neuropathic pain including diabetic neuropathy

04.07.03 Capsaicin cream Axsain®
02.05.05.01 Captopril 

Paediatrics only

04.07.03 Carbamazepine Tegretol

Trigeminal neuralgia

04.08.01 Carbamazepine 

Includes tablets, MR tablets, liquid and suppositories. (Chewtabs discontinued)


Suppositories are HIGH COST in primary care (£120.00 for 5)


MHRA/CHM Advice on switching:


Category 1: ensure patient is maintained on a specific manufacturer's product. 

06.02.02 Carbimazole 
03.07 Carbocisteine 

Capsules 375mg and syrup 250mg in 5ml


Oral solution 750mg in 10ml sachets are a cost-effective option if liquid is required.

11.08.01 Carbomer 980 gel (eye drops) Clinitas®, Viscotears®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

08.01.05 Carboplatin 
07.01.01 Carboprost Hemabate®
06.01.01.03 CareFine 
08.01.05 Carfilzomib Kyprolis®
11.08.01 Carmellose sodium 0.5% eye drops Optive Fusion®, Optive Plus®

Optive Plus contains castor oil in addition to carmellose and glycerol

Optive Fusion contains hyaluronic acid in addition to carmellose and glycerol

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

11.08.01 Carmellose unit dose eye drops Celluvisc®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

08.01.01 Carmustine Gliadel®
A2.05.02 Carobel, Instant®  

OTC product to thicken baby milk for reflux

02.04 Carvedilol 

Second line agent for heart failure after bisoprolol

05.02.04 Caspofungin 
07.04.04 Catheter Patency Solutions 
07.04.04 Catheter Patency Solutions 
07.04.04 Catheter Patency Solutions 
05.01.02.01 Cefaclor 
05.01.02.01 Cefalexin 
05.01.02.01 Cefixime Suprax®

GUM only

05.01.02.01 Cefotaxime 
05.01.02.01 Ceftazidime 
11.03.01 Ceftazidime  

Unlicensed special - Ophthalmology only

05.01.02.01 Ceftazidime/azibactam Zavicefta®

On microbiologist advice only

05.01.02 Ceftolozane 1g tazobactam 0.5g Zerbaxa®

Resistant pseudomonal infections  - microbiologist recommendation only

05.01.02.01 Ceftriaxone 
05.01.02.01 Cefuroxime 
11.03.01 Cefuroxime  

Unlicensed special - Ophthalmology only


 

11.03.01 Cefuroxime  Aprokam® Prophylaxis of endophthalmitis after cataract surgery
10.01.01 Celecoxib 

Not to be used in patients with cardiovascular disease

08.01.05 Cemiplimab Libtayo®
08.01.05 Ceritinib Zykadia
10.01.03 Certolizumab Pegol 
03.04.01 Cetirizine 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

13.02.01 Cetraben® 

Cream, Ointment, Lotion

08.01.05 Cetuximab Erbitux®
04.01.01 Chloral Betaine 

For use in pregnancy.


Note HIGH COST in primary care.

04.01.01 Chloral Hydrate 

Note HIGH COST in primary care

08.01.01 Chlorambucil 
05.01.07 Chloramphenicol Kemicetine®
11.03.01 Chloramphenicol 

NHS England low value medicine

A prescription for treatment of conjunctivitis should not be routinely offered in primary care as the condition is sel-limiting and will clear up on its own without the need for treatment

 

 

04.01.02 Chlordiazepoxide 

Alcohol withdrawal

13.11.02 Chlorhexidine 0.015% with cetrimide 0.15% Travasept®
13.11.02 Chlorhexidine 0.015% with Cetrimide 0.15% Tisept®
13.11.02 Chlorhexidine 0.05% 
12.02.03 Chlorhexidine 0.1%, neomycin 0.5% cream Naseptin®
13.11.02 Chlorhexidine 0.5% 
13.11.02 Chlorhexidine 2% in Isopropyl Alcohol 70% ChloraPrep®
13.11.02 Chlorhexidine 4% Hibiscrub®
11.03.01 Chlorhexidine digluconate 0.2% eye drops 

Unlicensed

12.03.04 Chlorhexidine gluconate 
05.04.01 Chloroquine 

Travel Prophylaxis - Private Prescription

02.02.01 Chlorothiazide 250mg in 5ml 

Paediatrics only

03.04.01 Chlorphenamine 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

04.02.01 Chlorpromazine 
04.06 Chlorpromazine 
14.04 Cholera vaccine Dukoral®

For adults travelling to at risk areas

12.03.01 Choline Salicylate Bonjela® Adult
03.02 Ciclesonide Alvesco®
08.02.02 Ciclosporin 

Prescribe by brand

08.02.02 Ciclosporin Sandimmun®
13.05.03 Ciclosporin  Vanquoral®
11.99.99.99 Ciclosporin A 0.1% Verkazia

For severe keratoconjuctivitis in children from four years of age and adolescents

11.99.99.99 Ciclosporin eye drops Ikervis®
01.03.01 Cimetidine 

Includes tablets and oral solution

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

09.05.01.02 Cinacalcet Mimpara®

NICE TA 117 Secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy.

 

NHS England commission cinacalcet for complex primary hyperparathyroidism in accordance with policy 16034/P.

 

 

04.06 Cinnarizine 

NHS England low value medication

A prescription for the treatment of travel sickness should not routinely be offered in primary care as the condition is appropriate for self-care.

05.01.12 Ciprofloxacin 

Restricted prescribing as per Microguide or NICE prescribing guidance

11.03.01 Ciprofloxacin 
15.01.05 Cisatracurium Nimbex®

Only for patients who are allergic to other agents and when vecuronium is not available.

08.01.05 Cisplatin 
04.03.03 Citalopram 

Maximum dose 40mg/ day, 20mg in elderly or liver dysfunction.  Refer to MHRA and local advice concerning QQT prolongation

08.01.03 Cladribine 
08.01.03 Cladribine  Mavenclad®

Approved in accordance with NICE TA493 for treating relapsing–remitting multiple sclerosis.

05.01.05 Clarithromycin 

Intravenous infusion

05.01.05 Clarithromycin 
05.01.06 Clindamycin  Restricted indications - refer to PHT Microguide antimicrobial guidelines
05.01.06 Clindamycin 

Restricted prescribing as per Microguide or NICE prescribing guidance

05.01.06 Clindamycin 

Unlicensed special listed in Drug Tariff

Paediatrics only

07.02.02 Clindamycin Dalacin®
13.06.01 Clindamycin 1% Dalacin T®
13.06.01 Clindamycin/ tretinoin gel Treclin®
19.23 Clinifast  Red, Green, Blue, Yellow and beige lines

Available in 1m, 3m and 5m lengths.

19.20 Clinipod 20ml x 25 pods sodium chloride 0.9%

Normal saline is the irrigation solution of choice. all irrigation solutions should be applied at body temperature. tap water is only to be used according to local policy for leg washing and all chronic and acute wounds will be cleansed with a setile, single use solution, if required.

19.21 Clinipore tape 2.5cm x 5m 
19.21 Clinipore tape 5cm x 5m 
19.14 Clinisorb 10cm x 10cm 

Sterile activated charcoal cloth. Apply as a secondary dressing over an appropriate primary dressing. Exudate will reduce the dressings effectiveness. Can be cut to size. Can be used in the management of malodourous wounds such as fungating wounds, pressure ulcers, leg ulcers and diabetic foot ulcers.

19.14 Clinisorb 10cm x 20cm 

Sterile activated charcoal cloth. Apply as a secondary dressing over an appropriate primary dressing. Exudate will reduce the dressings effectiveness. Can be cut to size. Can be used in the management of malodourous wounds such as fungating wounds, pressure ulcers, leg ulcers and diabetic foot ulcers.

19.14 Clinisorb 15cm x 25cm 

Sterile activated charcoal cloth. Apply as a secondary dressing over an appropriate primary dressing. Exudate will reduce the dressings effectiveness. Can be cut to size. Can be used in the management of malodourous wounds such as fungating wounds, pressure ulcers, leg ulcers and diabetic foot ulcers.

04.08.01 Clobazam 

Epilepsy only - SLS

 

MHRA advice on switching:

 

Category 2: need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

13.04 Clobetasol Propionate 0.05% Dermovate®
13.04 Clobetasol propionate 0.05% shampoo Etrivex®
13.04 Clobetasone Butyrate 0.05% Eumovate®
05.01.10 Clofazimine 
04.01.01 Clomethiazole 
06.05.01 Clomifene Citrate 

Secondary Care initiated

 

Fertility treatment

04.03.01 Clomipramine 

Psychiatry only: refer to anxiety treatment guidelines

04.08.01 Clonazepam 

MHRA advice on switching:

 

Category 2: need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

04.08.02 Clonazepam Injection 
02.05.02 Clonidine Catapres®
04.07.04.02 Clonidine 
20 Clonidine oral solution 

Premedication/sedation of children prior to surgery

02.09 Clopidogrel 

Prescribe generically

02.09 Clopidogrel 1mg in 1ml 

Unlicensed special listed in Drug Tariff

 

Paediatrics only

07.02.02 Clotrimazole 

10% vaginal cream


200mg pessaries


500mg pessary

12.01.01 Clotrimazole 1% Canesten®
13.10.02 Clotrimazole 1%  

NHSE low value medication

A prescription for the treatment of ringworm or athlets foot should not routinely be offered in primary care as the condition is appropriate for self-care

04.02.01 Clozapine 

Specialist use only.  Special requirements for monitoring.

13.05.02 Coal tar lotion 5% Exorex®
13.05.02 Coal tar ointment 

Coal tar 2%, 5%, 10% w/w in an ointment base

 

Unlicensed special on BAD list and in Drug Tariff

13.05.02 Coal tar paste BP 
13.05.02 Coal tar scalp pomade  

Unlicensed special on BAD list and in Drug Tariff

 

Coal tar solution BP 6% w/w and salicyclic acid 2% w/w in emulsifying ointment

13.05.02 Coal tar solution BP 3.3% w/w and propylene glycol 20% in Synalar gel 

Included on BAD specials list 2014

13.05.02 Coal tar solution BP 5% in betamethasone valerate 0.025% ointment  

Unlicensed special on BAD list and in Drug Tariff.

13.05.02 Coal tar solution BP 6% w/w and salicylic acid 6% w/w in Ung. Merck 
02.02.04 Co-amilofruse (amiloride/furosemide) 

2.5mg/20mg and 5mg/40mg tablets

02.02.04 Co-amilozide (amiloride/hydrochlorothiazide) 

2.5mg/25mg and 5mg/50mg tablets

05.01.01.03 Co-Amoxiclav 

Restricted indications - please refer to Microguide or NICE prescribing guidance

19.23 Coban 2 Comfort foam layer (layer 1) 10cm x 3.5m 
19.23 Coban 2 Comfort foam layer (layer 1) 15cm x 3.5m 

15cm width bandage should be used for applying to the knee and thigh of patients with chronic oedema.

19.23 Coban 2 Compression layer (layer 2) 10cm x 4.5m 
19.23 Coban 2 Compression layer (layer 2) 15cm x 4.5m 

The Coban 2 15cm width bandage should be used for applying reduced compression to the knee and thigh of patients with chronic oedema.

19.23 Coban 2 Layer compression system Kit 

Multi-layer compression bandage kit. Bandages of choice for lymphoedema/coedema management.


Coban 2 system is second-line for patients requiring full compression where Actico is considered inappropriate, known latex allergies or slippage may be a concern.

19.23 Coban 2 Lite Comfort foam layer (layer 1) 10cm x 2.7m 
19.23 Coban 2 Lite Comfort foam layer (layer 1) 15cm x 2.7m 

The Coban 2 lite comfort 15cm width bandage should be used for applying reduced compression to the knee and thigh of patients with chronic oedema.

19.23 Coban 2 Lite Compression layer (layer 2) 10cm x 3.5m 
19.23 Coban 2 Lite Compression layer (layer 2) 15cm x 3.5m 

15cm width bandage should be used for applying reduced compression to the knee and thigh of patients with chronic oedema.

19.23 Coban 2 Lite compression system Kit 

Designed to be more comfitable to patients less tolerant of compression therapy and/or who require reduced compression thepray.


This system is designed to be used as a kit and should not be used with other wadding or bandages.


 

04.09.01 Co-Beneldopa Madopar®
15.02 Cocaine 

Cocaine paste 25%


Cocaine solution 5%


Anaesthetics, A&E , ENT only

11.07 Cocaine 4% eye drops 
04.09.01 Co-Careldopa Sinemet®
04.09.01 Co-Careldopa Duodopa®

Specialist use in line with NHSE Commissioning Policy D04/P/e

13.06.02 Co-Cyprindiol 

Dermatology only – for women who also wish to receive oral contraception

01.06.02 Co-danthramer 

Includes capsules and suspension.  Only for treatment of terminally ill patients.

03.09.01 Codeine Linctus BP 

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

04.07.02 Codeine Phosphate injection 
01.04.02 Codeine phosphate tablets 
04.07.02 Codeine phosphate tablets 

Moderate to severe pain

10.01.04 Colchicine tablets 
09.06.04 Colecalciferol 20,000 units Fultium-D3®
09.06.04 Colecalciferol 25,000 unit oral solution Invita D3®
09.06.04 Colecalciferol 3200 unit capsules Fultium-D3®
09.06.04 Colecalciferol 50,000 unit oral solution Invita D3®
09.06.04 Colecalciferol 800 units Fultium-D3®, Invita D3®
09.06.04 Colecalciferol 800 units Desunin®

For patients who prefer a tablet formulation

02.12 Colesevelam  Cholestagel®

Symptomatic bile salt salt malabsorption with severe diarrhoea - second line after cholestyramine. Consultant gastroenterologist only.

01.09.02 Colestyramine Questran®
02.12 Colestyramine 
02.12 Colestyramine Questran®

Contains sucrose

02.12 Colestyramine Questran® Light

Sugar-free

05.01.07 Colistimethate sodium for injection or nebulisation Colomycin®

via nebuliser for non-CF bronchiectasis - refer to shared care agreement

05.01.07 Colistimethate sodium for injection or nebulisation Colomycin® Promixin® Cystic fibrosis in accordance with NHSE policy A01/P/b
05.01.07 Colistimethate sodium inhaler Colobreathe®
13.10.05 Collodion Flexible BP 
01.01.01 Co-magaldrox Maalox®

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

06.04.01.01 Combined continuous HRT patch Evorel® Conti
06.04.01.01 Combined continuous HRT tablet Kliofem, Kliovance, Femoston Conti
06.04.01.01 Combined cyclical HRT patch Evorel® Sequi

Patches only are formulary

06.04.01.01 Combined cyclical HRT tablet Elleste-Duet®, Femoston

Elleste Duet first choice for cost


Femoston 1/10 or 2/10


 

07.03.01 Combined Hormonal Contraceptives NuvaRing®

Secondary care initiated

07.03.01 Combined Hormonal Contraceptives Qlaira®

Only on specialist recommendation where contraception and relief of peri-menopausal symptoms is required 

07.03.01 Combined Hormonal Contraceptives Logynon ED®
07.03.01 Combined Hormonal Contraceptives Microgynon 30 ED®
07.03.01 Combined Hormonal Contraceptives Loestrin 30®
07.03.01 Combined Hormonal Contraceptives Femodene® ED
19.06 Comfeel Plus Ulcer 10cm x 10cm 

Absorbant hydrocolldoid dressing with added alginate for absorption, a vapour-permeable film backing and bevelled edge.

19.06 Comfeel Plus Ulcer 15cm x 15cm 

Absorbant hydrocolldoid dressing with added alginate for absorption, a vapour-permeable film backing and bevelled edge.

19.06 Comfeel Plus Ulcer 4cm x 6cm 

Absorbant hydrocolldoid dressing with added alginate for absorption, a vapour-permeable film backing and bevelled edge.

19.23 Comfifast  

Available in 1m, 3m and 5m lengths.

09.02.02.01 Compound sodium lactate intravenous infusion 
19.23 Comprilan 10cm x 5m 

Reusable system (washable) High cotton content. For specialist chronic oedema management.

06.01.06 Contour TS® 

Category 1 acceptable

05.01.08 Co-trimoxazole 

Restricted use - refer to BNF and microguide

05.01.08 Co-trimoxazole 

Restricted use - refer to BNF

05.04.08 Co-trimoxazole 
06.01.06 Coutour Next® 

Category 2

08.01.05 Crisantaspase Erwinase®
08.01.05 Crizotinib Xalkori®
13.03 Crotamiton Eurax®
19.15 Cutimed Sorbact Swab 4cm x 6cm 

DACC-coated, hydrophobic, antimicrobial wound contact layer. Primary dressing for contaminated, colonised or infected superficial or deep wounds including superficial wounds. traumatic, post-operative or dehisced wounds, ulcers and fungal infections in the groin, skin folds or between digits.

19.15 Cutimed Sorbact Swab 7cm x 9cm 

DACC-coated, hydrophobic, antimicrobial wound contact layer. Primary dressing for contaminated, colonised or infected superficial or deep wounds including superficial wounds. traumatic, post-operative or dehisced wounds, ulcers and fungal infections in the groin, skin folds or between digits.

04.06 Cyclizine 
13.10.04 Cyclomethicone 50% / Isopropyl myristate 50% solution Full Marks solution

Physical (non-chemical) insecticide for managment of head lice.

NHS England low value medication

A prescription for the treatment of head lice should not routinely be offered in primary care as the condition is suitable for self-care

11.05 Cyclopentolate eye drops and unit dose eye drops 

0.5 % and 1% drops and preservative-free unit dose drops (Minims)

08.01.01 Cyclophosphamide 

Injection, tablets

03.04.01 Cyproheptadine Periactin®

For SSRI overdose

18 Cyproheptadine tablets Periactin®

Serotonin syndrome

08.03.04.02 Cyproterone 

Secondary Care initiated

06.04.02 Cyproterone Acetate 
08.01.03 Cytarabine 
02.08.02 Dabigatran Pradaxa®

VTE Prophylaxis following elective hip and knee replacement (full course to be supplied by hospital).


Stroke prevention in non-valular AF


DVT and PE treatment and secondary prevention

08.01.05 Dabrafenib Tafinlar®
08.01.05 Dacarbazine 
08.01.05 Dacomitinib monohydrate Vizimpro®
08.01.02 Dactinomycin Cosmegen Lyovac®
05.01.07 Dalbavancin Xydalba®

On microbiologist advice only

02.08.01 Danaparoid Orgaran®
06.07.02 Danazol 

Hereditary angioedema - unlicensed indication

10.02.02 Dantrolene capsules 
18 Dantrolene injection 

Neuroleptic malignant syndrome

15.01.08 Dantrolene Sodium Dantrium Intravenous®
06.01.02.03 Dapagliflozin Forxiga▼®

Green For use in type 2 diabetics

 

Red For use in type 1 diabetics

05.01.10 Dapsone 

Dermatitis herpetiformis - dermatology only

05.01.07 Daptomycin Cubicin®

Consultant microbiologist only

08.01.05 Daratumumab Darzalex®
09.01.03 Darbepoetin Alfa Aranesp®
07.04.02 Darifenacin Emselex®
05.03.01 Darunavir Prezista®

HIV infection only

05.03.01 Darunavir and Cobicistat Rezolsta®

HIV infection only

05.03.03.02 Dasabuvir Exviera®
08.01.05 Dasatinib Sprycel®
08.01.02 Daunorubicin 
09.01.03 Deferasirox Exjade®

Commissioned by NHS England for iron chelation in thalassaemia, sickle cell and rare inherited anaemias (Policy 16070/P)

09.01.03 Deferiprone Ferriprox®

Commisioned by NHS England for iron chelation in thalassaemia, sickle cell and rare inherited anaemias (Policy 16070/P)

08.03.04.02 Degarelix Firmagon®
09.06.07 DEKAs/DEKAs Plus 

Vitamin and mineral supplements for use when recommended by a specialist in patients with cystic fibrosis 

05.01.03 Demeclocycline 

SIADH treatment only


Note HIGH COST in primary care

06.06.02 Denosumab Prolia®

May be initiated in primary care or first injection in secondary care


Prescribe by brand name (Prolia)

06.06.02 Denosumab XGEVA®

Secondary Care initiated


Prescribe by brand name (XGEVA)

13.08.02 Dermacolor® 

Dermatology only. Other brands (Covermark, Keromask, Veil) may be prescribed on specialist advice - all ACBS.)

13.02.01 Dermamist® spray 

White soft paraffin 10% in liquid paraffin and coconut oil

13.02.01 Dermatonics® Heel Balm® 

Contains 25% urea

13.09 Dermax® shampoo benzalkonium chloride 0.5%
13.02.01 Dermol® 

500 Lotion and Cream

18 Desferrioxamine injection 
09.01.03 Desferrioxamine Mesilate 

Commissioned by NHS England for iron chelation in thalassaemia, sickle cell and rare inherited anaemias (Policy 16070/P)

15.01.02 Desflurane 
03.04.01 Desloratadine 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

06.05.02 Desmopressin 

Sublingual tablets are second line

07.03.02.01 Desogestrel 75mcg tablets Cerelle®

Use generic in primary care or Cerelle in peanut/soya allergy

06.03.02 Dexamethasone 
12.01.01 Dexamethasone and ciprofloxacin Cilodex®
11.04.01 Dexamethasone eye drops Maxidex®
11.04.01 Dexamethasone intravitreal implant Ozurdex®
11.04.01 Dexamethasone preservative free unit dose  
12.01.01 Dexamethasone with neomycin Otomize®
11.04.01 Dexamethasone with neomycin and polymyxin B sulphate Maxitrol®
12.01.01 Dexamethasone,framycetin and gramicidin Sofradex®
04.04 Dexamfetamine 

Children - CAMHS initiation only

CAMHS Shared care agreement for Hampshire will be available on iDOCs

Adults - diagnosis and treatment initiation via Hampshire ADHD service (provided by Surrey and Borders Partnership NHSFT)

 

Awaiting shared care guidelines

08.01 Dexrazoxane Savene®

For the treatment of anthracycline extravasation in accordance with PHT guidelines.


Contact oncology pharmacist.

09.02.02.02 Dextran 70® 
04.07.02 Diamorphine Injection 

Severe pain

04.07.02 Diamorphine nasal spray Ayendi®

For paediatric emergency use only


Refer to Drug Therapy Guideline

04.01.02 Diazepam 

Short term use only

04.08.02 Diazepam Injection 
04.08.02 Diazepam Rectal Tubes 
10.02.02 Diazepam tablets 
02.05.01 Diazoxide 250mg in 5ml 

Unlicensed special listed in Drug Tariff

 

Paediatrics only

20 Dibotermin Alfa, rhBMP-2 InductOs®

Contact directorate pharmacist for advice/orders


NHS England are responsible for commissioning use in complex spinal surgery at specialist centres (Policy 16063/P)

10.01.01 Diclofenac 

EC tablets, SR capsules, suppositories, injection


Dispersible tablets only if necessary

13.08.01 Diclofenac Solaraze®
15.01.04.02 Diclofenac 

IM injection only in primary care.

10.03.02 Diclofenac Gel 1% 

Knee and hand OA

 

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

10.01.01 Diclofenac with Misoprostol Arthrotec 50 and 75®

Only for patients with high risk of GI bleed

18 Dicobalt edetate injection 

Cyanide poisoning

01.02 Dicycloverine tablets 

High cost in primary care

05.03.01 Didanosine Videx®

HIV infection only

08.03.01 Diethylstilbestrol 
13.04 Diflucortolone Valerate 0.1% Nerisone®
13.04 Diflucortolone Valerate 0.3% Nerisone Forte®
02.01.01 Digoxin 
02.01.01 Digoxin 
02.01.01 Digoxin specific antibody fragments Digifab®

For cardiac glycoside (digoxin) toxicity

18 Digoxin specific antibody fragments Digifab®

Digoxin overdose

04.07.02 Dihydrocodeine 

Non MR tablets only

04.07.02 Dihydrocodeine MR 
02.06.02 Diltiazem 

60mg tablets - prescribe generically

01.07.04 Diltiazem 2% Cream  Anoheal®

Only for chronic anal fissures unresponsive to GTN.

 

Unlicensed in the UK.

02.06.02 Diltiazem Hydrochloride 

Dilzem SR, Adizem SR, Tildiem Retard (twice daily dosage).


Different versions of modified-release preparations containing more than 60mg diltiazem hydrochloride may not have the same clinical effect. To avoid confusion between these different formulations of diltiazem, prescribers should specify the brand to be dispensed.

02.06.02 Diltiazem Hydrochloride 

Adizem XL, Dilzem XL, Viazem XL, Zemtard XL Tildiem LA (once daily dosage).


Different versions of modified-release preparations containing more than 60mg diltiazem hydrochloride may not have the same clinical effect. To avoid confusion between these different formulations of diltiazem, prescribers should specify the brand to be dispensed.

18 Dimercaprol injection 
13.05.03 Dimethyl fumarate Skilarence®
07.01.01 Dinoprostone Prostin E2®
08.01.05 Dinutuximab beta Qarziba®

NICE TA 538: Dinutuximab beta for treating neuroblastoma

13.10.03 Diphenylcyclopropenone in acetone 0.00001-6.0% w/v 

For use in dermatology only.


Diphenylcyclopropenone (DCP) is a highly sensitising agent used to treat alopecia areata and resistant viral warts as topical immunotherapy. It should be applied only in Dermatology departments by a trained professional.


Unlicensed special on BAD list


 

13.02.01 Diprobase® 

Zerobase is a lower cost alternative for primary care prescribing

02.09 Dipyridamole MR capsules Persantin® Retard
11.99.99.99 Disodium edetate 0.37%  
06.06.02 Disodium Pamidronate 

Secondary Care only

02.03.02 Disopyramide 
07.04.01 Distigmine Bromide Ubretid®

Urology only

04.10.01 Disulfiram Antabuse®

Substance Misuse Service only

13.05.02 Dithranol Dithrocream®
13.05.02 Dithranol in Lassar's Paste 

Strengths 0.1%. 0.5%, 1%, 2%, 4%, 10%, 15%

 

Unlicensed  special on BAD list

13.05.02 Dithranol pomade 0.4%  

Dithranol 0.4% w/w, salicylic acid 2%, emulsifying wax 25% , liquid paraffin to 100%


Unlicensed special on BAD list

18 DMSA (succimer) capsules 
02.07.01 Dobutamine 
08.01.05 Docetaxel 
01.06.02 Docusate sodium 

Includes capsules and oral solution (Stimulant/softener)

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

05.03.01 Dolutegravir 

HIV infection only

05.03.01 Dolutegravir, abacavir & lamivudine Triumeq®

HIV infection only NHSE commissioning policy B06/p/a 

04.06 Domperidone 
04.11 Donepezil 

Alzheimers Disease

Dementia associated with Parkinsons disease or Lewy bodies - Priorities Committee Policy Statement 25

 

 

02.07.01 Dopamine 
05.03.01 Doravirine Pifeltro®

For use in line with NHSE policy 190137P

03.07 Dornase Alfa Pulmozyme®

Cystic fibrosis  -  commissioned by NHS England

11.06 Dorzolamide generic
11.06 Dorzolamide 2% with timolol 0.5% Cosopt iMulti
11.06 Dorzolomide 2% with Timolol 0.5% generic
13.02.01 DoubleBase® 

Zerodouble is the lower cost alternative for prescribing in primary care.

03.05.01 Doxapram Dopram®
15.01.07 Doxapram 
02.05.04 Doxazosin 

Modified release tablets are NON-FORMULARY

07.04.01 Doxazosin 

Modified release tablets are NON-FORMULARY

04.03.01 Doxepin 

For dermatology use only - pruritus

13.03 Doxepin Xepin®

Second line on dermatology recommendation only

08.01.02 Doxorubicin 
08.01.02 Doxorubicin Caelyx®
05.01.03 Doxycycline 
05.04.01 Doxycycline 

Travel Prophylaxis - Private Prescription

13.06.02 Doxycycline capsules 
13.02.02 Drapolene® cream 

NHS England low value medication

A prescription for the treatment of nappy rash should not routinely be offered in primary care as the condition is appropriate for self-care

02.03.02 Dronedarone Multaq®

Second-line option strictly in accordance with the criteria in NICE TA 197

04.06 Droperidol Xomolix®

Prevention and treatment of post-operative nausea and vomting in paediatrics.

06.01.02.03 Dulaglutide 

For type 2 diabetes

04.03.04 Duloxetine 

Mental Health specialists only to initiate for depression/GAD.

 

 

04.07.03 Duloxetine 
07.04.02 Duloxetine 

Stress incontinence in women

 

 

19.06 DuoDerm Extra Thin 10cm x 10cm 

To aid debriding, promote granulation, occlusive barrier.


For light to medium exuding wounds ONLY. Ensure correct size is applied; overlap the wound by at least 2 cm . odour from dressing constituents can be a concern to patients.


Not suitable for infected wounds unless oberved frequently. Not indicated routinely on diabetic foot wounds - contact local diabetic/foot protection team for advice.

19.06 DuoDerm Extra Thin 5cm x 10cm 

To aid debriding, promote granulation, occlusive barrier.


For light to medium exuding wounds ONLY. Ensure correct size is applied; overlap the wound by at least 2 cm . odour from dressing constituents can be a concern to patients.


Not suitable for infected wounds unless oberved frequently. Not indicated routinely on diabetic foot wounds - contact local diabetic/foot protection team for advice.

19.06 DuoDerm Extra Thin 7.5cm x 7.5cm 

To aid debriding, promote granulation, occlusive barrier.


For light to medium exuding wounds ONLY. Ensure correct size is applied; overlap the wound by at least 2 cm . odour from dressing constituents can be a concern to patients.


Not suitable for infected wounds unless oberved frequently. Not indicated routinely on diabetic foot wounds - contact local diabetic/foot protection team for advice.

13.05.03 Dupilumab Dupixent®

NICE TA 534: Dupilumab for treating moderate to severe atopic dermatitis

19.15 Durafiber Ag 10cm x 10cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

19.15 Durafiber Ag 15cm x 15cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

19.15 Durafiber Ag 2cm x 45cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

19.15 Durafiber Ag 4cm x 10cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

19.15 Durafiber Ag 4cm x 20cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

19.15 Durafiber Ag 4cm x 30cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

19.15 Durafiber Ag 5cm x 5cm 

A highly absorbent, non-woven, sliver gelling fibre dressing. Use as a primary dressing for moderately to high exuding wounds where there is infection.

08.01.05 Durvalumab Imfinzi®
13.02.01 E45® 

Zerocream is a lower cost alternative for primary care prescribing

07.02.02 Econazole Gyno-Pevaryl®
09.01.03 Eculizumab Soliris®
13.02.01 Eczmol® cream 

Contains 1% chlorhexidine. Can also be used as a soap substitute

02.08.02 Edoxaban Lixiana®

Stroke prevention in non-valvular AF

 

DVT and PE treatment and secondary prevention

05.03.01 Efavirenz Sustiva®

HIV infection only

05.03.03.02 Elbasvir/grazoprevir Zepatier®
09.01.04 Eltrombopag Revolade®
01.05 Eluxadoline Truberzi®
13.02.01 Emollin® spray 

50:50 liquid paraffin/white soft paraffin aerosol spray

06.01.02.03 Empagliflozin Jardiance▼®
05.03.01 Emtricitabine Emtriva®

HIV infection only

05.03.01 Emtricitabine + tenofovir alafenamide Descovy®

HIV infection

05.03.01 Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera®

HIV infection only

13.02.01 Emulsifying Ointment BP 
02.05.05.01 Enalapril  
08.01.05 Encorafenib Braftovi®
05.03.01 Enfuvirtide Fuzeon®

HIV infection only

02.08.01 Enoxaparin Clexane ®

Prescribe by BRAND name

02.08.01 Enoxaparin (biosimilar) Inhixa®

Prescribe by BRAND name

04.09.01 Entacapone 
05.03.03.01 Entecavir Baraclude®

Chronic hepatitis B in line with NICE TA 153

15.01.02 Entonox® 

50% nitrous oxide, 50% oxygen

08.02.02 Envarsus® Tacrolimus

Second-line for the renal transplant (when other preparations have unacceptable side effects).  Used under the advice of renal transplant specialists ONLY.

08.03.04.02 Enzalutamide Xtandi®
13.11 Eosin solution 2% w/v 

Included in BAD specials list 2014

13.02.01 Epaderm® 

Dermatology only in secondary care. Listed in DT as appliance.

12.02.02 Ephedrine 0.5% and 1% nasal drops 

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

02.07.02 Ephedrine hydrochloride injection 
13.02.01 Epimax® 

Epimax is a cost effective alternative to Diprobase cream

08.01.02 Epirubicin 
02.02.03 Eplerenone tablets 

Left ventricular dysfunction (LVEF <40%) and clinical evidence of heart failure after recent myocardial infarction. NYHA class II CHF and left ventricular systolic dysfunction (LVEF <30%) in addition to standard optimal therapy.

09.01.03 Epoetin alfa Eprex®
09.01.03 Epoetin beta NeoRecormon®
02.08.01 Epoprostenol Flolan®

Restricted Item Information on restriction - Restricted to Neonatal unit, Surgery and Critical Care only

09.06.04 Ergocalciferol 300,000 units per ml 
07.01.01 Ergometrine maleate 
07.01.01 Ergometrine Maleate and Oxytocin Syntometrine®
08.01.05 Eribulin Halaven®
08.01.05 Erlotinib Tarceva®
08.01.05 Erlotinib Tarceva®
05.01.02.02 Ertapenem Invanz®

Microbiology recommendation only

06.01.02.03 Ertugliflozin Steglatro®
05.01.05 Erythromycin Erymax®

GUM only

05.01.05 Erythromycin 
05.01.05 Erythromycin 
11.03.01 Erythromycin 0.5% 

Unlicensed

13.06.02 Erythromycin tablets 
13.06.01 Erythromycin with zinc acetate Zineryt®
04.03.03 Escitalopram 

Refer to MHRA and local advice concerning QT prolongation and  dose restrictions

02.04 Esmolol 

Critical care and theatres only

01.03.05 Esomeprazole 

Includes tablets and capsules

02.11 Etamsylate Dicynene®

Restricted Item Information on restriction - Gynaecology use only

10.01.03 Etanercept Enbrel®

Prescribe by brand name

13.05.03 Etanercept (biosimilar) injection Benepali® Prescribe by brand name
10.01.03 Etanercept biosimilar Benepali®

Prescribe by brand name

13.05.03 Etanercept injection Enbrel®

Prescribe by brand name

09.05.01.02 Etelcalcetide Parsabiv®
05.01.09 Ethambutol  
18 Ethanol (alcohol) injection 
02.13 Ethanolamine Oleate 
08.03.01 Ethinylestradiol 

Oncology use only. High cost in primary care.

07.03.01 Ethinylestradiol / levonorgestrel phased pill TriRegol®, Logynon®

Consilient brand = Triregol

07.03.01 Ethinylestradiol 20 mcg / norethisterone 1mg Loestrin 20®
07.03.01 Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel®, Mercilon®

Consilient brand = Gedarel 20/150

07.03.01 Ethinylestradiol 30mcg / desogestrel 150mcg Gedarel®, Marvelon®

Consilient brand = Gedarel 30/150

07.03.01 Ethinylestradiol 30mcg / gestodene 75 mcg Millinette®, Femodene®,Sofiperla®

Consilient brand = Millinette 30

07.03.01 Ethinylestradiol 30mcg / levonorgestrel 150mcg Rigevidon®, Microgynon 30®, Levest®

Consilient brand = Rigevidon

07.03.01 Ethinylestradiol 35 mcg / noresthisterone 1mg Norimin®
07.03.01 Ethinylestradiol 35 mcg / noresthisterone 500mcg Ovysmen®, Brevinor®
07.03.01 Ethinylestradiol 35 mcg / norgestimate 250 mcg Cilique®

Cliest has been discontinued July 2019

04.08.01 Ethosuximide 

Capsules are HIGH COST in primary care

 

MHRA advice on switching:

 

Category 3: usually unnecessary to ensure that patients are maintained on a specific manufacturer's product unless there are specific concerns, such as patient anxiety and risk of confusion or dosing errors.

15.02 Ethyl Chloride Cryogesic® Spray

Anaesthetics, A&E, surgery only

15.01.01 Etomidate Hypnomidate®
07.03.02.02 Etonorgestrel Nexplanon®

Implant - only to be inserted and removed by trained doctor/nurse

08.01.04 Etoposide 
08.01.04 Etoposide 
05.03.01 Etravirine Intelence®

HIV infection only

13.02.01 Eucerin® Intensive 

Contains 10% urea

18 European Viper Venom Antivenom 
09.06.04 Evacal D3® 

Calcium carbonate 1500mg/colecalciferol 400 units

08.01.05 Everolimus Afinitor®
02.12 Evolocumab Repatha®

primary hypercholesterolaemia or mixed dyslipidaemia

13.02.01 Excetra®  

Cost effective alternative to Cetraben cream

08.03.04.01 Exemestane 
06.01.02.03 Exenatide Byetta▼®

Twice daily injection - type 2 diabetes

06.01.02.03 Exenatide prolonged release Bydureon▼®

Once weekly injection for type 2 diabetes

19.13 Exufiber 10cm x 10cm 

For infected/heavily exudating wounds. Do NOT use on dry or low exudating wounds. Requires a secondary dressing.

19.13 Exufiber 15cm x 15cm 

For infected/heavily exudating wounds. Do NOT use on dry or low exudating wounds. Requires a secondary dressing.

19.13 Exufiber 2cm x 45cm 

Apply in a cavity wound or on shallow wounds. Should overlap the wound margins.

19.13 Exufiber 4.5cm x 10cm 

Apply in a cavity wound or on shallow wounds. Should overlap the wound margins.

19.13 Exufiber 4.5cm x 20cm 

Apply in a cavity wound or on shallow wounds. Should overlap the wound margins.

19.13 Exufiber 4.5cm x 30cm 

Apply in a cavity wound or on shallow wounds. Should overlap the wound margins.

19.13 Exufiber 5cm x 5cm 

For infected/heavily exudating wounds. Do NOT use on dry or low exudating wounds. Requires a secondary dressing.

02.12 Ezetimibe Ezetrol®

Third-line treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia where;



  • Known statin intolerance 

  • Contraindication to statin.

10.01.04 Febuxostat Adenuric®

Option if allopurinol contraindicated or not tolerated.  Refer to local guidance on management of gout.

02.06.02 Felodipine 

Second line option after amlodipine or if low dose required in elderly (2.5mg tablets)

02.12 Fenofibrate 

Mixed dyslipidaemia unresponsive to statins

04.07.02 Fentanyl 

Most cost effective brand in primary care is Mezolar Matrix

15.01.04.03 Fentanyl 
04.07.02 Fentanyl sublingual tablets Abstral®

Incident and breakthrough pain in opioid tolerant cancer patients not responding to usual rescue medications. Prescribe by brand name

09.01.01.02 Ferric Carboxymaltose Ferinject®

Restricted to use in patients unable to receive Monofer® e.g. renal patients requiring doses of up to 1g to be given by an IV bolus and paediatrics


 

09.01.01.01 Ferric maltol Feraccru®

Restricted to gastroenterology - only for the treatment of iron deficiency anaemia in adult patients with inflammatory bowel disease.

09.01.01.01 Ferrous Fumarate 
09.01.01.01 Ferrous Sulphate 
03.04.01 Fexofenadine 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

20 Fibrin Sealant Evicel®

Restricted Item Information on restriction - Urology - Partial nephrectomy surgery. ENT - pharyngeal resection, named surgeon only.


 

05.01.07 Fidaxomicin Dificlir®

Under advice of microbiology only.

09.01.06 Filgrastim 

Commissioned by NHS England for neutropenia according to Trust Guidelines. Use product with lowest acquisition cost.

06.04.02 Finasteride 
02.03.02 Flecainide 
02.03.02 Flecainide 

Liquid for use in infants and children unable to swallow tablets

01.06.05 Fleet Phospho-soda® 
13.02.01 Flexitol® 

Contains 25% urea

13.02.01 Flexitol® 

Contains 10% urea

13.04 Flucinolone Acetonide 0.0025% Synalar 1 in 10 Dilution®
13.04 Flucinolone Acetonide 0.00625% Synalar 1 in 4 Dilution®
13.04 Flucinolone Acetonide 0.025% Synalar®
05.01.01.02 Flucloxacillin 
05.02 Fluconazole 

Resistant candida, with specialist advice

11.03.02 Fluconazole 0.2% eye drops 

Unlicensed

05.02 Flucytosine Ancotil®
08.01.03 Fludarabine Phosphate 
06.03.01 Fludrocortisone 
13.04 Fludroxycortide tape Haelan®
15.01.07 Flumazenil 
18 Flumazenil injection 
12.01.01 Flumetasone 0.02% with clioquinol 1% ear drops 

Previously Locorten-Vioform

11.04.01 Fluocinolone intravitreal implant Iluvien®

Diabetic macular oedema NICE TA 301

11.08.02 Fluorescein Sodium Eye drops, injection

 


 

11.04.01 Fluorometholone eye drops FML®

Low potency

08.01.03 Fluorouracil 
13.08.01 Fluorouracil 5% cream Efudix®
04.03.03 Fluoxetine 

First line agent in general population


20mg capsules are the most cost-effective presentation for doses of 20mg, 40mg and 60mg.


Oral solution 20mg in 5ml can be used for patients with swallowing difficulties or if a 10mg dose is required.

04.02.01 Flupentixol Depixol®
04.03.04 Flupentixol Fluanxol®
04.02.02 Flupentixol Decanoate Depixol®

Psychiatry only

04.02.02 Flupentixol Decanoate Depixol® Conc.

Psychiatry only

04.02.02 Flupentixol Decanoate Depixol® Low Volume

Psychiatry only

04.02.02 Fluphenazine decanoate injection Modecate®

Modecate is going to be discontinued and will no longer be available after the end of 2018.


New patients should not be initiated on Modecate and existing patients will need to be identified and an alternative treament prescribed.

10.01.01 Flurbiprofen tablets 

Ophthalmology initiation only

08.03.04.02 Flutamide 
03.02 Fluticasone furoate & vilanterol Relvar Ellipta®

COPD 92/22 strength only – refer to COPD guidelines. Asthma step 4 or 5 BTS

12.02.01 Fluticasone furoate nasal spray Avamys®

Second-line corticosteroid for allergic rhinitis.


 

03.02 Fluticasone propionate Flixotide®

MDI / Accuhaler

13.04 Fluticasone Propionate Cutivate®

Second Line - Dermatology and Paediatrics only

03.02 Fluticasone propionate and formoterol Flutiform®

Asthma only

03.02 Fluticasone propionate and salmeterol Sirdupla®, Seretide®, Sereflo ®

At high doses of Seretide, Accuhalers are significantly cheaper than MDIs and should be prescribed in preference to MDIs where possible.

 

Sirdupla and Sereflo - alternative combination inhaler for asthma only – prescribe by brand name. Note, only licensed for patients >18 years

12.02.01 Fluticasone propionate nasal spray Flixonase®
09.01.02 Folic Acid 
18 Fomepizole 

Ethylene glycol or methanol poisoning

02.08.01 Fondaparinux Arixtra®

For use in patients with a previous history of heparin induced thrombocytopenia (HIT) for thromboprophylaxis

Under advice of haematology for use in treatment of HIT (off-label use)

13.07 Formaldehyde Veracur®

NHS England low value medication

A prescription for the treatment of warts and verrucae should not routinely be offered in primary care as the condition is appropriate for self-care.

03.01.01.01 Formoterol fumarate Atimos® Modulite
03.01.01.01 Formoterol fumarate Easyhaler

First line LABA for COPD. Dry powder device

05.03.01 Fosamprenavir Telzir®

HIV infection only

04.06 Fosaprepitant Ivemend®

NHSE funded chemotherpay supportive drug


Only for patients unable to take any oral antiemetics or with anticipatory nausea and vomiting.

05.03.02.02 Foscarnet Sodium Foscavir®

CMV retinitis

05.01.07 Fosfomycin Fomicyt®

Consultant microbiologist recommendation only- refer to PHT microguide

05.01.07 Fosfomycin Monuril®

Community multi-resistant Extended-spectrum Beta-lactamase (ESBL) E. coli UTI - on advice from microbiology. 

Restricted prescribing as per Microguide or NICE prescribing guidance

06.01.06 FreeStyle Libre flash glucose monitoring sensors 

See referral criteria on front page

06.01.06 Freestyle Lite® 

Category 2

06.01.06 Freestyle Optium® 

Category 2

A2.02.01.02 Fresubin® Jucy 

For those patients who cant tolerate milk based Aymes shakes

08.03.04.01 Fulvestrant Faslodex®
13.05.02 Fumaderm®  

Moderate to severe psoriasis- unlicensed

02.02.02 Furosemide 
11.03.01 Fusidic Acid 1% 

Second line

13.10.01.02 Fusidic Acid 2% cream Fucidin®
04.07.03 Gabapentin 

Refer to chronic pain guidelines

04.11 Galantamine 

Alzheimers Disease

Dementia associated with Parkinsons disease or Lewy bodies - Priorities Committee Policy Statement 25

Cost effective brands for prescribing in primary care are Galazemic or Gazylan XL

 

19.20 Gamgee Drug Tariff (pink) 500g 

Used to absorb large amounts of exudate. Not to be used as primary dressing. If used in leg management always pad OUTSIDE the bandage to maintain adequate pressures (if compression to the leg).


Can be cut to size.

05.03.02.02 Ganciclovir Cymevene®

CMV infections only - intravenous

11.03.03 Ganciclovir 0.15% ophthalmic gel Virgan®
01.01.02 Gaviscon Advance 

Peptac or Acidex Advance is a cost effective alternative in primary care

 

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

01.01.02 Gaviscon Infant 
08.01.05 Gefitinib Iressa®
09.02.02.02 Gelatin Gelofusine®
08.01.03 Gemcitabine 
08.01.05 Gemtuzumab ozogamicin Mylotarg®
05.01.04 Gentamicin  refer to PHT Drug Therapy Guideline
05.01.04 Gentamicin 

via nebuliser for non-CF bronchiectasis - refer to shared care agreement

12.01.01 Gentamicin  
11.03.01 Gentamicin 0.3% 
11.03.01 Gentamicin 1.5%  Unlicensed
12.03.05 Glandosane® 

ACBS

08.02.04 Glatiramer Acetate Copaxone®
05.03.03.02 Glecaprevir/Pibrentasvir 
06.01.02.01 Gliclazide 

plain tablets - not MR

06.01.04 Glucagon GlucaGen® HypoKit
18 Glucagon GlucaGen® Hypokit

Beta-blocker overdose

06.01.04 GlucoGel® 
06.01.06 GlucoMen Areo® 

Category 1 acceptable

06.01.06 Glucomen LX sensors® 

Category 2

06.01.01.03 GlucoRx CarePoint 
06.01.01.03 GlucoRx FinePoint 
06.01.01.03 GlucoRx Lancets 
06.01.06 GlucoRx Nexus® 

Category 1 acceptable

06.01.01.03 GlucoRx Safety 

Only for patients unable to self administer

09.02.02.01 Glucose intravenous injection/infusion 

5%,10%,, 20%, 50%

06.01.06 Glucose test strips 

Refer to local guidance on preferred products.

01.06.02 Glycerol (Glycerin) 

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

 

11.99.99.99 Glycerol 15% eye drops  
02.06.01 Glyceryl Trinitrate 
02.06.01 Glyceryl Trinitrate GTN

300mcg tablets are cheaper than 500mcg in primary care

02.06.01 Glyceryl Trinitrate Nitromin®

Prescribe as brand 'Nitromin'

02.06.01 Glyceryl Trinitrate 
01.07.04 Glyceryl Trinitrate 0.4% Rectogesic®
07.04.04 Glycine 
03.01.04 Glycopyrrolate/ indacaterol inhaler Ultibro Breezhaler®

LABA+LAMA. Refer to COPD guidelines

03.01.02 Glycopyrronium Seebri Breezhaler®

LAMA in capsule for inhalation via Breezhaler device. Refer to COPD guidelines

20 Glycopyrronium oral solution 5mg in 5ml 

For hypersalivation

 

Unlicensed special listed in Drug Tariff

 

Paediatrics only

15.01.03 Glycopyrronium bromide 
13.12 Glycopyrronium bromide 0.05% w/v in water 

for iontophoresis

 

Unlicensed special on BAD list and in Drug Tariff

13.12 Glycopyrronium bromide 2% in cetomacrogol cream 

Unlicensed special on BAD list and in Drug Tariff

01.05.03 Golimumab Simponi®
10.01.03 Golimumab Simponi®
06.05.01 Gonadorelin HRF®

Secondary care only

06.07.02 Goserelin 
08.03.04.01 Goserelin Zoladex®
08.03.04.02 Goserelin Zoladex®
08.03.04.02 Goserelin Zoladex® LA
04.06 Granisetron 

For chemotherapy induced nausea and vomiting

02.05.03 Guanethidine Monosulphate Ismelin®

Pain Clinic only

04.04 Guanfacine Intuniv®

CAMHS Shared care agreement for Hampshire will be available on iDOCs

13.05.03 Guselkumab Tremfya®
04.02.01 Haloperidol 
04.02.02 Haloperidol Haldol Decanoate®

Psychiatry only

04.09.03 Haloperidol 
02.08.01 Heparin 10units per ml injection Hepsal®

Amber Initiation for use in paediatric patients only where being administered by community nurses

02.08.01 Heparin Calcium injection 
02.08.01 Heparin Sodium injection 
14.04 Hepatitis A vaccine 

Havrix, Avaxim, Vaqta, Vaqta Paediatric


For adults and children travelling to at risk areas - prescribe by brand name and check appropriate dose.

14.04 Hepatitis A vaccine with Hepatitis B vaccine  

Twinrix, Ambirix


For people travelling to at risk areas

14.04 Hepatitis A vaccine with typhoid vaccine 

Hepatyrix, ViATIM


For adults travelling to at risk areas

14.04 Hepatitis B vaccine 

Engerix B, HbvaxPRO, Fendrix


For people at increased risk of exposure to hepatitis B virus, at increased risk of complications of hepatitis B or post potential exposure to hepatitis B virus (including infants born to mothers carrying hepatitis B). 


 

13.11.02 Hibitane Obstetric® 
11.99.99.99 Holoclar®  

Ex vivo expanded autologous human corneal cells containing stem cells

11.05 Homatropine eye drops 
09.02.02.02 Human albumin solution 
14.04 Human papilloma virus vaccine Gardasil®

For use in routine immunisation programme - 12-13 years old, girls only

10.03.01 Hyaluronidase Hyalase®

Gynaecology - for perineal pain/scarring

02.05.01 Hydralazine 
06.03.01 Hydrocortisone Alkindi®

Paediatric use only

06.03.02 Hydrocortisone 
13.04 Hydrocortisone 
10.01.02.02 Hydrocortisone acetate Hydrocortistab®
06.03.02 Hydrocortisone sodium phosphate Efcortesol®

Secondary Care Initiated

06.03.02 Hydrocortisone sodium succinate Solu-Cortef®
13.04 Hydrocortisone 0.25% Crotamiton 10% Eurax-Hydrocortisone®
13.04 Hydrocortisone 1% with Clotrimazole 1% Canesten HC®
12.01.01 Hydrocortisone 1% with gentamicin 0.3% ear drops Gentisone® HC
13.04 Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort®
13.04 Hydrocortisone 1%, Urea 10% and Lactic Acid 5% Calmurid HC®
01.05.02 Hydrocortisone 10% rectal foam Colifoam®
12.03.01 Hydrocortisone 2.5mg mucoadhesive buccal tablets 
13.04 Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H®
06.03.02 Hydrocortisone acetate oral suspension 

Unlicensed special

 

Paediatrics only

13.04 Hydrocortisone Butyrate Locoid®
11.04.01 Hydrocortisone sodium phosphate 3.35mg/mL eye drops Softacort®
19.04 Hydrofilm 10cm x 12.5cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

19.04 Hydrofilm 10cm x 15cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

19.04 Hydrofilm 10cm x 25cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

19.04 Hydrofilm 12cm x 25cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

19.04 Hydrofilm 15cm x 20cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

19.04 Hydrofilm 20cm x 30cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

19.04 Hydrofilm 6cm x 7cm 

Dry, non infected wounds; retention of lines; fixation of secondary dressings. NB: Management of IV sites - refer to local guidlines

13.11.06 Hydrogen Peroxide 1% Crystacide®

Superficial bacterial skin infection

13.11.06 Hydrogen Peroxide Solution BP 

Solution 6% (20 vols)



Solution 3% (10 vols)


20 Hydroquinone, hydrocortisone and tretinoin Pigmanorm®

Hydroquinone 5% w/w, hydrocortisone 1% w/w and tretinoin 0.1% w/w


Unlicensed in the UK. On BAD specials list for melasma (maximum 6 months treatment).

13.02.01 Hydrous ointment (oily cream) 
09.01.02 Hydroxocobalamin (vitamin B12) 
18 Hydroxocobalamin for infusion Cyanokit®

Cyanide poisoning

08.01.05 Hydroxycarbamide 
10.01.03 Hydroxychloroquine tablets 
11.08.01 Hydroxyethylcellulose unit dose drops Minims® Artificial Tears

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

03.04.01 Hydroxyzine 

For dermatology use only in secondary care

 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

01.02 Hyoscine Butylbromide Buscopan®

Includes tablets and injection (for syringe drivers)

04.06 Hyoscine hydrobromide Scopoderm TTS®

Licensed for motion sickness but used for other unlicensed indications e.g. palliative care

NHS England low value medication

A prescription for the treatment of motion sickness should not routinely be offered in primary care as the condition is appropriate for self-care

04.06 Hyoscine Hydrobromide 
04.06 Hyoscine Hydrobromide Kwells

NHS England low value medication

A prescription for the treatment of motion sickness should not routinely be offered in primary care as the condition is appropriate for self-care

15.01.03 Hyoscine hydrobromide 
19.21 Hypafix® tape 

2.5cm, 5cm, 10cm

11.08.01 Hypromellose 0.3% eye drops and preservative-free eye drops 

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

06.06.02 Ibandronic Acid 

150mg tablet (monthly)

 

Use as per osteoporosis guidelines

06.06.02 Ibandronic Acid 

Oncology only- adjuvant treatment of post-menopausal breast cancer (off-licence)

06.06.02 Ibandronic Acid 

Post-menopausal osteoporosis if oral biphosphonates unsuitable or not tolerated

08.01.05 Ibrutinib Imbruvica®
07.01.01.01 Ibuprofen Pedea® injection

Restricted Item Information on restriction - Neonatal Unit only

10.01.01 Ibuprofen 

Oral suspension sugar free 100mg in 5ml, Tablets 200mg, 400mg , 600mg

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

10.03.02 Ibuprofen gel 

Knee and hand OA, 5% and 10%

 

Fenbid is most cost effective brand in primary care

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

10.01.01 Ibuprofen SR Brufen Retard®

Rheumatology, orthopaedics and Pain Clinic only

13.05.01 Ichthammol 

Ichthopaste, Icthaband

19.16 Ichthopaste 7.5cm x 6m 

Chronic eczema/dermatitis where occlusion is indicated. Zinc paste and ichthammol.


Ensure any residue is removed before re-bandaging. Patch testing is required prior to use. To be applied as per manufacturer's guidance. Not as a primary dressing or as a patch.

08.01.02 Idarubicin Zavedos®
02.08 Idarucizumab Praxbind®

Restricted Item Information on restriction - Specific reversal agent for dabigatran. On consultant haematologist advice only in cases of life-threatening bleeding or where emergency surgery is necessary.

08.01.05 Idelalisib Zydelig®
08.01.01 Ifosfamide 
08.01.05 Imatinib 
04.03.01 Imipramine 

Alternative to amitriptyline for peripheral neuropathic pain in adults - refer to chronic pain guideline

04.07.03 Imipramine 

Alternative to amitriptyline in peripheral neuropathic pain in adults - refer to chronic pain guidelines

13.07 Imiquimod Aldara®

External genital and perianal warts  - GUM only

 

Small superficial basal cell carcinomas (sBCCs)  - on dermatologist recommendation only

19.15 Inadine 5cm x 5cm 

Non-adherent dressing impregnated with 10% povidone-iodine. colour changes will indicates when to change dressing.


Management and prevention of infection in ulcers, minor burns and minor traumatic skin injuries. Not effective in medium to heavy exudate.

19.15 Inadine 9.5 x 9.5 

Non-adherent dressing impregnated with 10% povidone-iodine. colour changes will indicates when to change dressing.


Management and prevention of infection in ulcers, minor burns and minor traumatic skin injuries. Not effective in medium to heavy exudate.

02.02.01 Indapamide 

2.5mg tablets


Sustained release preparation (Natrilix 1.5mg SR) are NON-FORMULARY

05.03.01 Indinavir Crixivan®

HIV infection only

20 Indocyanine Green  

Surgical dye

10.01.01 Indometacin 
07.04.01 Indoramin 
14.04 Infanrix hexa®  

Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed).


For use in routine immunisation programme at 8 weeks old, 12 weeks old, 16 weeks old

14.04 Infanrix IPV® 

Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)


For use in routine immunisation programme - pre-schoool booster

14.04 Infanrix-IPV+Hib® 

Diphtheria (D), tetanus (T), pertussis (acellular component) (Pa), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)


 

A2.01 Infatrini Peptisorb 

See faltering growth guideline

A2.01 Infatrini® 

Energy Dense Feed

Should not be started in primary care without specialist advice

 

 

01.05.03 Infliximab Remicade®

Severe active Crohns disease in line with NICE TA 187, Acute exacerbation of sever active ulcerative colitis NICE TA 163, Moderately to severelty active ulcerative colitis NICE TA 329.  Prescribe by brand name

10.01.03 Infliximab Remicade®

Prescribe by brand name

01.05.03 Infliximab (biosimilar) Inflectra®

Severe active Crohns disease in line with NICE TA 187, Acute exacerbation of sever active ulcerative colitis NICE TA 163, Moderately to severelty active ulcerative colitis NICE TA 329.  Prescribe by brand name

01.05.03 Infliximab (biosimilar) Remsima®

Prescribe by brand name

13.05.03 Infliximab (biosimilar) for infusion Remsima®

Prescribe by brand name

13.05.03 Infliximab (biosimilar) for infusion Inflectra®

Prescribe by brand name

10.01.03 Infliximab biosimilar Remsima®

Prescribe by brand name

10.01.03 Infliximab biosimilar Inflectra®

Prescribe by brand name

13.05.03 Infliximab for infusion Remicade®
14.04 Influenza Vaccine Intanza®

Refer to Wesex PGDs for inclusion criteria

14.04 Influenza vaccine  seasonal,intramuscular

For adults over 65 years or in at risk groups, given annually as part of national programme, and pregnant women

14.04 Influenza vaccine intranasal Fluenz Tetra®

For children aged 2-8 (including school years R, 1-4)

08.01.05 Inotuzumab ozogamicin Besponsa®

NICE TA541 Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia

06.01.01.01 Insulin Humulin® S
06.01.01.01 Insulin Actrapid®
06.01.01.01 Insulin Insuman® Rapid
06.01.01.01 Insulin Aspart  NovoRapid®

1.6ml cartridges (PumpCart) are for Accucheck Insight insulin pumps only

06.01.01.01 Insulin aspart Fiasp®

Mealtime insulin - different formulation to Novorapid.

06.01.01.02 Insulin degludec Tresiba®

100units/ml strength

06.01.01.02 Insulin degludec 200 units/ml Tresiba®

Concentrated insulin 200 units/ml in prefilled pen ONLY. For people requiring larger doses, to reduce injection volume.

06.01.01.02 Insulin Detemir Levemir®
06.01.01.02 Insulin Glargine Lantus®
06.01.01.02 Insulin Glargine Toujeo®

Only initiate with advice from a diabetic consultant or diabetes specialist nurse

 

Concentrated insulin 300 units/ml in a prefilled pen only

 

For patients with large insulin requirements due to insulin resistance -  to reduce injection volumes

06.01.01.02 Insulin Glargine biosimilar 

First choice for patients needing a new basal analogue insulin

06.01.01.01 Insulin Glulisine Apidra®
06.01.01.01 Insulin Lispro 100 units/ml Humalog®

NB Kwikpen has 2 strengths - 100units/ml and 200units/ml.


 

06.01.01.01 Insulin Lispro 200 units/ml Humalog®

200units/ml


Concentrated insulin available in pre-filled pen ONLY

06.01.01.01 Insulin porcine  Hypurin® Porcine Neutral
08.02.04 Interferon Alfa IntronA®
10.02 Interferon beta-1a Avonex®, Rebif®
10.02.01 Interferon beta-1b Extavia®
09.03 Intralipid 20% 
19.07 IntraSite Conformable 10cm x 10cm 

Primary indicated for the treatment of necrotic and sloughy wounds, e.g. leg ulcers, pressure ulcers and non-infected diabetic foot ulcers. Not suitable for infected or heavily exudating wounds. Secondary dressings required.

19.07 IntraSite Conformable 10cm x 20cm 

Primary indicated for the treatment of necrotic and sloughy wounds, e.g. leg ulcers, pressure ulcers and non-infected diabetic foot ulcers. Not suitable for infected or heavily exudating wounds. Secondary dressings required.

19.07 IntraSite Conformable 10cm x 40cm 

Primary indicated for the treatment of necrotic and sloughy wounds, e.g. leg ulcers, pressure ulcers and non-infected diabetic foot ulcers. Not suitable for infected or heavily exudating wounds. Secondary dressings required.

07.03.04 Intra-uterine Contraceptive Devices Flexi-T® 300
07.03.04 Intra-uterine Contraceptive Devices GyneFix®
07.03.04 Intra-uterine Contraceptive Devices Multiload® 375
07.03.04 Intra-uterine Contraceptive Devices Nova-T® 380
07.03.04 Intra-uterine levonorgestrel Kyleena®
07.03.02.03 Intra-uterine Progestogen Only System Mirena®

Effective up to 5 years

07.03.02.03 Intra-uterine Progestogen Only System Jaydess®

Second line if Mirena not suitable.


Licensed for contraception only.


Effective up to 3 years

07.03.02.03 Intra-uterine Progestogen Only System Levosert®
06.02.02 Iodine and Iodide 

Hospital use only

19.15 Iodoflex 10g 

Cadexomer dressing with iodine. For the treatment of chronic exuding wounds. Not to be used on dry necrotic tissue.


Can apply up to 50g per dressing change, cover with a secondary dressing and change when paste is saturated. do NOT exceed 150g Iodoflex in 1 week, or more than 3 months single course of treatment.

19.15 Iodoflex 5g 

Cadexomer dressing with iodine. For the treatment of chronic exuding wounds. Not to be used on dry necrotic tissue.


Can apply up to 50g per dressing change, cover with a secondary dressing and change when paste is saturated. do NOT exceed 150g Iodoflex in 1 week, or more than 3 months single course of treatment.

08.01.05 Ipilimumab Yervoy®
03.01.02 Ipratropium bromide 

MDI


Nebules

03.01.04 Ipratropium bromide with salbutamol Combivent®

Nebules

02.05.05.02 Irbesartan 

Option for hypertension in diabetes

08.01.05 Irinotecan Hydrochloride 
09.01.01.01 Iron and Folic Acid Pregaday®
09.01.01.02 Iron Dextran CosmoFer®
09.01.01.02 Iron isomaltoside Monofer®

Preferred IV iron preparation at PHT.


Refer to IV Iron Drug Therapy Guideline

09.01.01.02 Iron Sucrose Venofer®

For patients on haemodialysis only

15.01.02 Isoflurane 
13.02.01 Isomol® 

Isomol is a cost effective alternative to Doublebase Gel

05.01.09 Isoniazid 
06.01.01.02 Isophane Insulin Hypurin® Porcine Isophane
06.01.01.02 Isophane Insulin Insulatard®
06.01.01.02 Isophane Insulin Humulin® I
06.01.01.02 Isophane Insulin Insuman® Basal
02.07.01 Isoprenaline injection  
02.06.01 Isosorbide Mononitrate 

Asymmetric dosage

02.06.01 Isosorbide Mononitrate MR 

25mg & 50mg MR preparation - prescribe as Capsules


60mg MR preparation - Prescribe as Chemydur 60XL tablets


Nocturnal angina and in cases of non-compliance.


13.06.01 Isotretinoin Isotrex® gel
13.06.02 Isotretinoin 
13.06.01 Isotretinoin with erythromycin Isotrexin®
01.06.01 Ispaghula husk granules 

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

05.02 Itraconazole 

Restricted prescribing as per Microguide or NICE prescribing guidance

02.06.03 Ivabradine 

NYHA Class II-IV stable chronic heart failure in line with NICE TA 267

02.06.03 Ivabradine 

Primary Care - only for initiation in stable angina where beta blockers contraindicated or not tolerated


Second Line for patients with contraindication or intolerance to betablockers or suboptimal response to diltiazem. Initiation by consultant cardiologist, diabetologist, respiratory physician, MOPRS only.)

03.07 Ivacaftor 

As per NHS England commissioning statement Cystic Fibrosis Modulator Therapies 19013P

13.06 Ivermectin cream Soolantra®
20 Ivermectin tablets 

Scabies, in combination with topical drugs, for the treatment of hyperkeratotic (crusted or ‘Norwegian’) scabies that does not respond to topical treatment alone.

08.02.04 Ixazomib Ninlaro®
13.05.03 Ixekizumab injection Taltz®
14.04 Japanese Encephalitis Vaccine Ixiaro®

Private Supply only

19.07 KerraLite Cool 6cm x 6cm 

Consider when pain is a significant factor.


For use on chronic wounds, painful wounds, skin conditions such as leg ulcers, radiation therapy damage, burns and scalds. May be used on low-exuding and non-exuding wounds to assist in autolytic debridement by hydration of necrotic and sloughy tissue and for absorption of exudate.

19.07 KerraLite Cool 8.5cm x 12cm 

Consider when pain is a significant factor.


For use on chronic wounds, painful wounds, skin conditions such as leg ulcers, radiation therapy damage, burns and scalds. May be used on low-exuding and non-exuding wounds to assist in autolytic debridement by hydration of necrotic and sloughy tissue and for absorption of exudate.

15.01.01 Ketamine injection 

Ketamine 100mg in 10ml pre-filled syringe - DCCQ only for emergency use (unlicenced)

13.09 Ketoconazole 2% shampoo 

NHS England low value medication

A prescription for treatment of dandruff should not routinely be offered in primary care as the condition is appropriate for self-care

06.01.06 Ketones test strips 

Recommendation to self-test for ketones must be maade by the diabetes specialist sevice.

10.01.01 Ketoprofen MR 

Inflammatory arthritis

11.08.02 Ketorolac Acular®
15.01.04.02 Ketorolac 
03.04.01 Ketotifen Zaditen®

Paediatrics only

19.12 Kliniderm Foam Silicone Border adhesive 10cm x 10m 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.12 Kliniderm Foam Silicone Border adhesive 10cm x 20cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.12 Kliniderm Foam Silicone Border adhesive 12.5cm x 12.5cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.

19.12 Kliniderm Foam Silicone Border adhesive 15cm x 15cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.

19.12 Kliniderm Foam Silicone Border adhesive 15cm x 20cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.

19.12 Kliniderm Foam Silicone Border adhesive 7.5cm x 7.5cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.

19.12 Kliniderm Foam Silicone non-adhesive 10cm x 10cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.12 Kliniderm Foam Silicone non-adhesive 10cm x 20cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.12 Kliniderm Foam Silicone non-adhesive 15cm x 15cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.12 Kliniderm Foam Silicone non-adhesive 20cm x 20cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.12 Kliniderm Foam Silicone non-adhesive 5cm x 5cm 

For use on moderately exuding wounds. Foam dressing should be left in place for up to 7 days. Exudate will be visible but change dressing when strike through is 1 cm from edge.


Foam dressings should not be used for pressure relief.

19.11 Kliniderm Superabsorbent Dressing  Kliniderm

 to replace Vliwasorb Pro  Sizes available, in packs of 10 unless stated otherwise:

10cm x 10cm
10cm x 15cm
10cm x 20cm
20cm x 20cm (pack 15)
20cm x 30cm

20cm x 40cm

19.23 K-Lite 10cm x 4.5cm 

second-line use after Ultra-Lite

13.08.01 LA Roche-Posay Anthelios XL SPF 50+ Cream® 

NHS England low value medicine

A prescription for sun protection should not routinely be offered in primary care as this is suitable for self-care.

Sun protection may be prescribed as per ACBS recommendations: Approved for skin protection against UV radiation in abnormal cutaneous photosensitivity. This includes genetic disorders, photodermatoses, vitiligo from radiotherapy and chronic or recurrent herpes simplex labialis.

02.04 Labetalol 
04.08.01 Lacosamide  Vimpat ®

Refractory epilepsy only

 

MHRA advice on switching:

 

Category 3: usually unnecessary to ensure that patients are maintained on a specific manufacturer's product unless there are specific concerns, such as patient anxiety and risk of confusion or dosing errors.

 

 

01.06.04 Lactulose solution 

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

05.03.01 Lamivudine Epivir®

HIV infection, hepatitis B

05.03.01 Lamivudine Zeffix®

HIV infection, hepatitis B

04.08.01 Lamotrigine 

MHRA advice on switching:

 

Category 2: need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

03.04.03 Lanadelumab Takhzyro®
08.03.04.03 Lanreotide Somatuline Autogel®

Reduction of secretions from pancreatic/enterocutaneous fistula if more than 4 weeks treatment is required(off-licence)

08.03.04.03 Lanreotide Somatuline® LA

Red Red for new patients

Amber with Shared Care Amber shared care for existing patients only

08.03.04.03 Lanreotide Somatuline Autogel®

Red Red for new patients

Amber with Shared Care Amber shared care for existing patients only

01.03.05 Lansoprazole 

Orodispersible tablets are restricted to patients unable to swallow capsules

NHS England low value medication

A prescription for mild infrequent indegestion and heartburn should not routinely be offered in primary care as the condtion is appropriate for self-care

09.05.02.02 Lanthanum carbonate Fosrenol ®

Red for renal dialysis patients

08.01.05 Lapatinib Tyverb®
09.08.01 L-Arginine 5g in 10ml injection 

Unlicensed

 

Paediatrics only

11.06 Latanoprost 

First line

11.06 Latanoprost 0.005% with Timolol 0.5% generic
11.06 Latanoprost 50micrograms/mL + timolol 5mg/mL Fixapost®
11.06 Latanoprost Preservative Free Monopost®

First choice where a preservative-free prostaglandin analogue is required

19.20 LBF Sterile No Sting Barrier Film 5 x 1ml 
19.20 LBF Sterile No Sting Barrier Film 5 x 2ml 
05.03.03.02 Ledipasvir and Sofosbuvir Harvoni®
10.01.03 Leflunomide tablets 

For the treatment of BK viraemia and nephropathy in renal transplant recipients

10.01.03 Leflunomide tablets  NOT FOR RENAL INDICATIONS
08.02.04 Lenalidomide  Revlimid®
09.01.06 Lenograstim Granocyte®

Commissioned by NHS England for neutropenia according to Trust Guidelines. Use product with lowest acquisition cost.

08.01.05 Lenvatinib Lenvima®
02.06.02 Lercanidipine 

Second line option after amlodipine - hypertension only

05.03.02.02 Letermovir Prevymis®
08.03.04.01 Letrozole 
19.20 Leukostrip 6.4cm x 76mm 

Available on FP10, more cost-effective than Steri-strip.

06.07.02 Leuprorelin 
08.03.04.02 Leuprorelin Acetate Lutrate® 1 month depot 3.75mg
08.03.04.02 Leuprorelin Acetate Lutrate® 3 month depot 22.5mg
08.03.04.02 Leuprorelin Acetate Prostap® SR
08.03.04.02 Leuprorelin Acetate Prostap® 3
05.05.02 Levamisole oral

Paediatrics only - available from special order manufacturers or importers

20 Levamisole 50mg tablets  

Roundworm infections

04.08.01 Levetiracetam 

Includes tablets and oral solution

 

MHRA advice on switching:

 

Category 3: usually unnecessary to ensure that patients are maintained on a specific manufacturer's product unless there are specific concerns, such as patient anxiety and risk of confusion or dosing errors.

15.02 Levobupivacaine Chirocaine®
04.09.01 Levodopa, carbidopa and entacapone Stalevo® Stanek®

Cost effective brand for prescribing in primary care is Stanek

05.01.12 Levofloxacin 

Restricted prescribing as per Microguide or NICE prescribing guidance

11.03.01 Levofloxacin 

 


Eye drops


Preservative free eye drops


 

13.03 Levomenthol  Menthoderm, Dermacool

0.5%, 1% and 2%


Menthoderm is the preferred product at PHT

04.02.01 Levomepromazine (methotrimeprazine) 

Prescribe as 25mg tablets - these can be divided to provide 6.25mg or 12.5 mg oral doses.


6mg tablets are only available as an unlicensed special at HIGH COST in primary care.

07.03.05 Levonorgestrel 

1.5mg stat tablet up to 72 hours post UPSI

07.03.02.01 Levonorgestrel tablets Norgeston®
20 Levosimendan for infusion 

Critical care only - refer to Drug Therpay Guideline

06.02.01 Levothyroxine tablets 
15.02 Lidocaine 
15.02 Lidocaine 10% spray 
15.02 Lidocaine 2.5% with Prilocaine 2.5% EMLA®
15.02 Lidocaine 4% solution Laryngojet
11.07 Lidocaine 4% with fluorescein 0.25% unit dose eye drops Minims®
15.02 Lidocaine 5% and Phenylephrine 0.5% 
15.02 Lidocaine 5% ointment 
15.02 Lidocaine medicated plaster 5% Versatis®

 Red     For acute pain associated with fractured ribs -  maximum two weeks treatment (off-licence indication). SECONDARY CARE ONLY.

Green  Neuropathic pain associated with herpes zoster infection (post-herpetic neuralgia). PRIMARY AND SECONDARY CARE.

 

15.02 Lidocaine with Adrenaline Xylocaine®
20 Lidocaine/adrenaline/tetracaine (LAT) 

Paediatrics only.

15.02 Lidocaine2% with Chlorhexidine 0.25% Instillagel®
15.02 Lignocaine 
19.20 LimbO waterproof leg protector 

Available as slim, normal and large build, standard leg and short leg.

01.06.07 Linaclotide Constella®

Moderate to severe irritable bowel syndrome with constipation as recommended in NICE CG 61

06.01.02.03 Linagliptin Trajenta▼®
05.01.07 Linezolid 

On microbiologist advice only - refer to PHT Microguide

06.02.01 Liothyronine sodium injection 
06.02.01 Liothyronine sodium tablets 

To be initiated by NHS secondary care only for approved indications

 

Note HIGH COST in primary care

08.01.05 Liposomal cytarabine-daunorubicin Vyxeos®
13.02.01 Liquid paraffin 50% white soft paraffin 50% ointment  50:50
01.06.03 Liquid Paraffin and Magnesium Hydroxide Emulsion BP 

Avoid use in the elderly

01.06.04 Liquid Paraffin and Magnesium Hydroxide Emulsion BP 

Avoid use in the elderly

 

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

06.01.02.03 Liraglutide Victoza®

Once daily injection for type 2 diabetes

04.04 Lisdexamfetamine Elvanse®

Children - CAMHS initiation only for ADHD refractory to methylphenidate

CAMHS Shared care agreement for Hampshire will be available on iDOCs

Adults - diagnosis and treatment initiation via Hampshire ADHD service (provided by Surrey and Borders Partnership NHSFT)

 

Awaiting shared care guidelines

02.05.05.01 Lisinopril 
04.02.03 Lithium Carbonate Liskonum®

Prescribe by brand name

Green Green      For Portsmouth CCG patients   

04.02.03 Lithium Carbonate Camcolit ®

Prescribe by brand name

 

Green Green      For Portsmouth CCG patients                                                

04.02.03 Lithium Carbonate Priadel®

Prescribe by brand name

Green Green      For Portsmouth CCG patients   

04.02.03 Lithium Citrate Li-Liquid®

Prescribe by brand name

Green Green      For Portsmouth CCG patients   

04.02.03 Lithium Citrate Priadel®Liquid

Prescribe by brand

Green Green      For Portsmouth CCG patients   

11.04.02 Lodoxamide eye drops Alomide®

Ophthalmology recommendation only

04.03.01 Lofepramine 
04.10.03 Lofexidine BritLofex®

Substance Misuse Services only

08.01.01 Lomustine 
01.04.02 Loperamide 

Includes capsules and syrup

NHS England low value medicine

A prescription for treatment of acute diarrhoes should not routinely be offered in primary care as the condition is appropriate for self care

05.03.01 Lopinavir and Ritonavir Kaletra®

HIV infection only

03.04.01 Loratadine 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

04.01.02 Lorazepam 
04.01.02 Lorazepam 

Short term use only

15.01.04.01 Lorazepam 
02.05.05.02 Losartan 
11.04.01 Loteprednol eye drops Lotemax®

Low potency

03.07 Lumacaftor/Ivacaftor Orkambi®

As per NHS England commissioning statement Cystic Fibrosis Modulator Therapies 190137P

09.01.04 Lusutrombopag Mulpleo®
08.01.05 Lutetium (177Lu) oxodotretide Lutathera®

NICE TA539 Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours

05.01.03 Lymecycline generic
13.06.02 Lymecycline capsules 
18 Macrogol '3350' Klean-Prep®

For gut decontamination for overdose with agents not bound by activated charcoal (e.g. iron & lithium).

01.06.04 Macrogol oral powder Laxido®, Laxido Paediatric®, Cosmocol®

For chronic constipation or faecal impaction

01.06.05 Macrogols Klean-Prep®, Moviprep®
11.08.01 Macrogols eye drops Systane®

Eye drops, Unit dose drops, Systane Balance

09.05.01.03 Magnesium Aspartate Magnaspartate®

10mmol magnesion per sachet

09.05.01.03 Magnesium glycerophosphate Neomag®

4mmol magnesium per tablet

09.05.01.03 Magnesium Glycerophosphate 

Unlicensed special - only to be used if Magnaspartate is not suitable or not tolerated.

01.06.04 Magnesium Hydroxide Mixture BP 

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

09.05.01.03 Magnesium Sulphate 
13.10.05 Magnesium Sulphate Paste BP 
01.01.01 Magnesium Trisilicate Mixture BP 

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

13.10.04 Malathion 0.5% aqueous solution Derbac-M®

NHS England low value medication

A prescription for the treatment of head lice should not routinely be offered in primary care as the condition is suitable for self-care

02.02.05 Mannitol 10% and 20% 
05.05.01 Mebendazole 

NHS England low value medicine

Treatment of threadworms is suitable for self-care and mebendazole can be sold over the counter for children and adults over the age of 2 years.

Prescribing in line with NICE antibiotic guidelines for children aged 6 months to 2 years only

01.02 Mebeverine tablets 

Note oral suspension is available but is high cost in primary care


£187.00 for 300ml (DT February 2017)

19.15 Medihoney Antibacterial Honey Apinate 1.9cm x 30cm 

Non-adherent, non-absorbent, protease modulating matrix, sterile. Contains calcium and antibacterial honey.

19.15 Medihoney Antibacterial Honey Apinate 10cm x 10cm 

Non-adherent, non-absorbent, protease modulating matrix, sterile. Contains calcium and antibacterial honey.

19.15 Medihoney Antibacterial Medical Honey 20g 

Useful on sinus wounds. indicated for infected or critically colonised wounds. Can be effective if malodour present, as a desloughing agent or in the treatment of necrotic wounds.

19.15 Medihoney Antibacterial Medical Honey 50g 

Useful on sinus wounds. indicated for infected or critically colonised wounds. Can be effective if malodour present, as a desloughing agent or in the treatment of necrotic wounds.

13.02 medihoney barrier cream 50g MediHoney®

2nd line for nappy rash (if improvement is not seen with current first line, Derma S). Under the advice of tissue viability ONLY

On advice of the tissue viability team. Medihoney may be prescribed for patients with severe moisture damage

19.15 Medihoney HCS 11cm x 11cm 

An all-in-one dressing that combines 63% Medihoney in a hydrogel dressing with superabsorbent polymer.

19.15 Medihoney HCS 11cm x 11cm Adhesive

An all-in-one dressing that combines 63% Medihoney in a hydrogel dressing with superabsorbent polymer.


The adhesive dressing does not require a secondary dressing. For dry to moderately exudating wounds.

19.15 Medihoney HCS 6cm x 6cm 

An all-in-one dressing that combines 63% Medihoney in a hydrogel dressing with superabsorbent polymer.

19.15 Medihoney Tulle Dressing 10cm x 10cm 

For superficial wounds. Strong woven dressings impregnated with antibacterial honey, sterile. 

06.04.01.02 Medroxyprogesterone Acetate Provera®
07.03.02.02 Medroxyprogesterone acetate Sayana Press®

13-weekly subcutaneous injection


May be self-administered following training by HCP.


Women who self-administer will require sharps container and completed healthcare waste collection referral form to request collection by local council.

07.03.02.02 Medroxyprogesterone Acetate Depo-Provera®

12-weekly intramuscular injection

08.03.02 Medroxyprogesterone Acetate Provera®
10.01.01 Mefenamic Acid 

Dysmenorrhoea

05.04.01 Mefloquine Lariam®

Travel Prophylaxis - Private Prescription

08.03.02 Megestrol Acetate Megace®
04.01.01 Melatonin Paediatrics

CAMHS / Community Paediatrics only if sleep hygiene measures have failled. 

 

2mg m/r (Circadin) first line, but off license.  Unlicensed tablets/capsules second line - a brand name must be specified.  Kidnaps oral suspension 1mg in 1ml (unlicensed) if liquid required

10.01.01 Meloxicam 
08.01.01 Melphalan 
04.11 Memantine 

Moderate and severe Alzheimers Disease.

 

Dementia associated with Parkinsons disease or Lewy bodies - Priorities Committee Policy Statement 25

 

Shared Care Guideline awaited

 

 

09.06.06 Menadiol Sodium Phosphate 
06.01.06 Mendor Discreet Cartridge® 

Category 2

14.04 Meningococcal A, C, W135, and Y conjugate vaccine 

Menveo, Nimenrix


For use in routine immunisation programme - 14 years old (year 9)


Asplenia/splenic dysfunction - refer to guidance

14.04 Meningococcal group B Vaccine Bexsero®

For use in routine immunisation programme at 8 weeks, 16 weeks and 1 year old


Asplenia/splenic dysfunction - refer to guidance

14.04 Menitorix® 

Haemophilus type b and Meningococcal group C conjugate vaccine


For use in routine childhood vaccination programme at age 1 year


Asplenia/splenic dysfunction - refer to guidance

03.08 Menthol and Eucalyptus Inhalation BP 1980 

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

15.02 Mepivacaine Scandonest Plain®

For use as a intra-cervical block to faciliate insertion of intra-uterine devices only.

03.04.02 Mepolizumab Nucala®

Only to be initiated in tertiary specialist commissioned centres.


 

08.01.03 Mercaptopurine 
01.05.03 Mercaptopurine tablets 

Crohn's disease - unlicensed indication

05.01.02.02 Meropenem Meronem®

Second line for adults with febrile neutropenia

01.05.01 Mesalazine Asacol®

Prescribe by brand name.  Includes tablets, foam enema and suppositories

 

In primary care the most cost effective brand is Octasa

01.05.01 Mesalazine Pentasa®

Prescribe by brand name.  Includes tablets and retention enema

01.05.01 Mesalazine Salofalk®

Prescribe by brand name.  Includes granules (sachets) and retention enema 2g in 59ml

01.05.01 Mesalazine m/r tablets Octasa®

Prescribe by brand name

01.05.01 Mesalazine m/r tablets Mezavant® XL

Second-line mesalazine prep - prescribe by brand name - once daily dosing

13.02.02 Metanium® ointment 

NHS England low value medication

A prescription for the treatment of nappy rash should not routinely be offered in primary care as the condition is appropriate for self-care

02.07.02 Metaraminol injection 

 Anesthetics and Critical Care only


unlicensedunlicensed

06.01.02.02 Metformin 

If liquid is required prescribe metformin oral solution sugar free 500mg in 5ml (150ml) as listed in Drug Tariff

06.01.02.02 Metformin & pioglitazone Competact®

For patients established on both agents

06.01.02.02 Metformin Hydrochloride Glucophage® SR, Sukkarto® SR

Second line - only if standard metformin not tolerated in an adequate dose.

 

Preferred product in primary care is Sukkarto SR tablets - prescribe by brand name

04.10.03 Methadone 1mg/ml 

Substance Misuse services only

04.10 Methadone Hydrochloride 

Substance Misuse Services only

05.01.13 Methenamine Hippurate Hiprex®
01.05.03 Methotrexate 

Crohn's dsease - unlicensed indication


Tablets 2.5mg


Nordimet   - prefilled pen


Metoject PEN - prefilled pen

08.01.03 Methotrexate 
10.01.03 Methotrexate 

Tablets 2.5mg


Nordimet   - prefilled pen


Metoject PEN - prefilled pen


 

13.05.03 Methotrexate  

Tablets 2.5mg


Nordimet   - prefilled pen


Metoject PEN - prefilled pen

13.05.02 Methoxypsoralen 

PUVA – unlicensed

13.08.01 Methyl-5-Aminolevulinate Metvix®

Secondary Care Only (Dermatology only - photodynamic therapy for actinic keratosis

01.06.01 Methylcellulose Celevac®

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

02.05.02 Methyldopa 

for use in pregnancy

01.06.06 Methylnaltrexone Relistor®

For opioid induced constipation where there has been inadequate response to standard laxatives.  On specialist palliative care recommendation only in primary care

04.04 Methylphenidate 

Children - CAMHS initiation only 

CAMHS Shared care agreement for Hampshire will be available on iDOCs

Adults - diagnosis and treatment initiation via Hampshire ADHD service (provided by Surrey and Borders Partnership NHSFT)

 

Awaiting shared care guidelines

04.04 Methylphenidate Hydrochloride MR 

Children - CAMHS initiation only

Prefered product is Matoride XL

CAMHS Shared care agreement for Hampshire will be available on iDOCs

Adults - diagnosis and treatment initiation via Hampshire ADHD service (provided by Surrey and Borders Partnership NHSFT)

 

Awaiting shared care guidelines

06.03.02 Methylprednisolone 

Methylprednisolone acetate (Depo-Medrone) - Green


Methylprednisolone sodium succinate injection  - Amber under protocol from specialist for MS exacerbations

10.01.02.02 Methylprednisolone Acetate Depo-Medrone®

Depo-Medrone may be used by any of the following routes: intramuscular, intra-articular, periarticular, intrabursal, intralesional or into the tendon sheath.

10.01.02.02 Methylprednisolone acetate with lidocaine Depo-Medrone® with Lidocaine
18 Methylthioninium chloride Proveblue®

Methaemoglobinaemia

20 Methylthioninium chloride Proveblue®

Ifosfamide-induced encephalopathy (off-licence)


Vasopressor in septic shock (off-licence)

04.06 Metoclopramide 
02.02.01 Metolazone 

Metolazone is now discontinued in the UK and is only available as an unlicensed special or import.

02.04 Metoprolol 
02.04 Metoprolol Tartrate Betaloc®
05.01.11 Metronidazole 
05.01.11 Metronidazole 
07.02.02 Metronidazole Zidoval®
13.10.01.02 Metronidazole 0.75% cream Rozex®

Rosacea

13.10.01.02 Metronidazole 0.75% gel  Anabact® Rozex®

Anabact - malodorous fungating tumours and ulcers


Rozex - rosacea

06.07.03 Metyrapone Metopirone®

Secondary Care only

20 Mexiletine capsules 
05.02.04 Micafungin Mycamine®

On microbiology advice only

07.02.02 Miconazole Gyno-Daktarin®

 Vaginal capsule (Ovule) 1.2g single dose


 

12.03.02 Miconazole Daktarin®

NHS England low value medication

A prescription for the treatment of oral thrush should not be routinely offered in primary care as the condition is appropriate for self-care.

06.01.01.03 Microdot Max Safety 

Only for patients unable to self administer

15.01.04.01 Midazolam 
04.01.01 Midazolam injection 

by subcutaneous injection for symptom control in palliative care

04.08.02 Midazolam Oromucosal Solution Buccolam®

Please prescribe using brand name in primary care

02.07.02 Midodrine tablets 
08.01.05 Midostaurin Rydapt®
07.01.02 Mifepristone Mifegyne®
02.01.02 Milrinone injection Primacor®
02.05.01 Minoxidil 

Renal Unit only

07.04.02 Mirabegron Betmiga®

Refer to local OAB guidelines

04.03.04 Mirtazapine 

Second line agent

07.01.01 Misoprostol tablets 
08.01.02 Mitomycin 
11.99.99.99 Mitomycin C intra-ocular injection 

Unlicensed

08.01.02 Mitoxantrone (Mitozantrone) 
15.01.05 Mivacurium Mivacron®

Critical Care only

14.04 MMRVaxPRO® 

Measles, Mumps and Rubella vaccine (live)


For use in routine immunisation programme at 1 year old and preschool booster

06.01.06 Mobile Test Cassette® 

Category 2

04.03.02 Moclobemide 

Specialist initiation only

04.04 Modafinil 

Hypersomnolence associated with Parkinson's disease only (off-licence)

A2.03.02 Modulen IBD®  
13.04 Mometasone Furoate 0.1% Elocon®
12.02.01 Mometasone furoate nasal spray 

Second-line corticosteroid

03.03.02 Montelukast 
04.07.02 Morphine sulfate 

Includes MR capsules (Zomorph), sachets, injection, oral solution

20 Morphine sulfate 10mg in 10ml Intrasite gel 

Acute painful skin reactions due to radiotherapy

12.03.04 Mouthwash Solution tablets 
05.01.12 Moxifloxacin 

Restricted prescribing as per Microguide or NICE prescribing guidance

02.05.02 Moxonidine 

Consultant recommendation only

A2.05.02 Multi-thick®  
09.06.07 Multivitamin preparations Abidec®

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

Patients suitable for Healthy start vitamins between the ages of 6months and 4years.

09.06.07 Multivitamin preparations Dalivit®

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

Patients suitable for Healthy start vitamins between the ages of 6months and 4years.

12.02.03 Mupirocin 2% ointment Bactroban Nasal®

For MRSA only

13.10.01.01 Mupirocin 2% ointment Bactroban®
08.02.01 Mycophenolate Mofetil 
08.02.01 Mycophenolate Mofetil 
08.02.01 Mycophenolate Sodium Myfortic®

Transplant patients only. Prescribe by BRAND name

20 Mydricaine No.1 and No.2 injection 
06.01.01.03 Mylife Lancets 
06.01.01.03 Mylife Penfine Classic 
06.01.06 MyLife Pura® 

Category 1 acceptable

10.01.01 Nabumetone 

Rheumatology only

06.07.02 Nafarelin 
02.06.04 Naftidrofuryl 
04.10.01 Nalmefene Selincro®

Refer to local pathway

01.06.06 Naloxegol Moventig®

For opioid induced constipation where there has been inadequate response to standard laxatives.

15.01.07 Naloxone  
18 Naloxone injection 

Opioid overdose

04.10.01 Naltrexone Adepend®

Alcohol dependence

04.10.03 Naltrexone Nalorex®

opioid dependence

04.10 Naltrexone Hydrochloride Opizone®

Substance Misuse services only

06.04.03 Nandrolone Deca-Durabolin®

Secondary Care only

10.01.01 Naproxen 
11.03.01 Natamycin 5% eye drops 

Unlicensed

02.04 Nebivolol 

5mg tablets only (2.5mg tablets are available but are significantly more expensive than 5mg tablets - for a 2.5mg dose use half a 5mg tablet)

 

For use in hypertension in patients intolerant of other beta-blockers. Hypertension and Cardiology specialities only.

 

 

A2.01 Neocate LCP 

Amino Acid Formula

Second line option

First line for severe reactions/anaphylactic reactions/reactions to breast milk

 

Refer to secondary care

15.01.06 Neostigmine 
10.02.01 Neostigmine tablets 
15.01.06 Neostigmine with glycopyrronium 
11.08.02 Nepafenac  Nevanac®

Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients  - full course to be supplied by hospital.

08.01.05 Neratinib  Nerlynx ®
04.06 Netupitant and Palonosetron Akynzeo®

For prevention of chemotherapy induced nausea and vomiting only - refer to CINV guidelines


 

13.02.01 Neutrogena® Dermatological Cream 

NPF

05.03.01 Nevirapine Viramune®

HIV infection only

02.06.03 Nicorandil 

Third line agent for angina

04.10.02 Nicotine Replacement Therapy 

Includes all formulations and brands


Primary Care -  as part of smoking cessation programme.


Secondary care  - refer to PHT NRT guideline (only a limited range of NRT products are stocked at PHT)

02.06.02 Nifedipine Apidine XL®, Adipine MR
02.06.02 Nifedipine Adalat® Retard

Off-licence use in premature labour - maternity services only.


Refer to Trust guidelines

02.06.02 Nifedipine Adalat® LA

30mg & 60mg MR tablets. Once daily dosage. Prescribe as brand 'Adalat LA'.

02.06.02 Nifedipine Coracten® XL

Once daily dose

02.06.02 Nifedipine Adalat® Retard
02.06.02 Nifedipine Coracten® SR

Twice daily dosage

07.01.03 Nifedipine capsules 

Maternity services only for premature labour  - refer to guideline

08.01.05 Nilotinib Tasigna®
02.06.02 Nimodipine Nimotop®
03.11 Nintedanib Ofev®
03.11 Nintedanib Vargatef®
08.01.05 Nintedanib  Vargatef®
08.01.05 Niraparib  Zejula®
04.01.01 Nitrazepam 

Short term use only

05.01.13 Nitrofurantoin 

Suspension is HIGH COST in primary care

05.01.13 Nitrofurantoin Macrobid®

Twice daily dosage, refer to local management of infection guidance

15.01.02 Nitrous oxide 
08.02.04 Nivolumab Opdivo®
01.03.01 Nizatidine 

For use during rantidine shortage only in patients who require treatment with a H2 antagonist

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

19.20 Non-woven fabric swab 7.5cm x 7.5cm Sterile

Used for general purpose swabbing and cleansing.

02.07.02 Noradrenaline acid tartrate injection norepinephrine

Anaesthetics and critical care only

06.04.01.02 Norethisterone 
07.03.02.01 Norethisterone Noriday®
07.03.02.01 Norethisterone Micronor®
08.03.02 Norethisterone 
07.03.02.02 Norethisterone enantate Noristerat®

8 weekly injection

14.05.01 Normal Human Immunoglobulin 

National demand management programme applies

04.03.01 Nortriptyline 

Alternative to amitriptyline for peripheral neuropathic pain in adults - refer to chronic pain guideline


Note HIGH COST compared to amitriptyline

04.07.03 Nortriptyline 

Alternative to amitriptyline for peripheral neuropathic pain in adults


Note HIGH COST in primary care compared to amitriptyline

19.20 Nurse It dressing Pack 

Pair of powder-free latex vinyl gloves, 7 non-woven swabs, 1 compartment tray, disposable forceps, laminate paper sterile field, large apron, paper towel and white polythene disposable bag.

10.02 Nusinersen Spinraza®
A2.05.02 Nutilis Clear® 
A2.05.02 Nutilis® Powder 
A2.01 Nutramigen 1 with LGG® 

Cows Milk Protein Allergy

 

First Line Agent

 

Extensively Hydrolysed formula

A2.01 Nutramigen 2 with LGG® 

Cows Milk Protein Allergy

 

Extensively Hydrolysed Formula

 

First line agent

A2.01 Nutramigen Puramino ® 

Amino Acid Formula

 

First line for severe reactions/ anaphylactic reactions/ reactions to breast milk

 

Refer to secondary care

A2.01 Nutriprem 2  

For pre term infants

Follow discharge information - review at 6 months corrected age

Powder should be prescribed - ready made liquid for exceptional circumstances only (immunocompromised patients)

 

 

12.03.02 Nystatin oral suspension Nystan®

Prescribe as Nystan brand

13.10.02 Nystatin with Chlorhexidine cream Nystaform®
01.09.01 Obeticholic acid Ocaliva®
08.02.03 Obinutuzumab Gazyvaro ®
08.02.04 Ocrelizumab Ocrevus®
11.08.02 Ocriplasmin Jetrea®
08.03.04.03 Octreotide Sandostatin®

Red Red for new patients

Amber with Shared Care Amber shared care for existing patients only

08.03.04.03 Octreotide Sandostatin Lar®

Red Red for new patients

Amber with Shared Care Amber shared care for existing patients only

18 Octreotide injection 

Sulphonylurea overdose

06.04.01.01 Oestrogen only HRT gel Oestrogel
06.04.01.01 Oestrogen only HRT patch Estradot, Evorel
06.04.01.01 Oestrogen only HRT tablet Elleste-Solo

Elleste Solo 1 and 2mg tablets


 

06.04.01.01 Oestrogens for HRT FemSeven® Conti
06.04.01.01 Oestrogens for HRT Indivina®
06.04.01.01 Oestrogens for HRT FemSeven®
06.04.01.01 Oestrogens for HRT Sandrena®
06.04.01.01 Oestrogens for HRT Elleste-Duet Conti®

HRT Continous COmbined

06.04.01.01 Oestrogens for HRT Angeliq®

HRT Continous Combined

 

Only for women unable to tolerate other options

07.02.01 Oestrogens, Topical Estring®
07.02.01 Oestrogens, Topical Ovestin®

Estriol 0.1% cream

07.02.01 Oestrogens, Topical Vagifem®
07.02.01 Oestrogens, Topical Gynest®

Estriol 0.01% cream

08.02.03 Ofatumumab Arzerra®
05.01.12 Ofloxacin 

Restricted prescribing as per Microguide or NICE prescribing guidance

11.03.01 Ofloxacin Eye drops Exocin®

Severe bacterial infections

 

 

01.07.03 Oily phenol injection BP 
04.02.01 Olanzapine 
04.02.01 Olanzapine 10mg injection 

Only for use in accordance with rapid tranquilisation guidelines

08.02.04 Olaparib Lynparza®
12.01.03 Olive Oil Ear Drops 

NHS England low value medication

A prescription for the removal of earwax should not routinely be offered in primary care as the condition is appropriate for self-care

11.04.02 Olopatadine eye drops Opatanol®
01.05.01 Olsalazine tablets 

Tablets only

03.04.02 Omalizumab Xolair®

Severe persistent asthma with important allergic component in line with NICE TA 278. Adults and children over 6 years. Chronic spontaneous urticaria NICE TA 339

05.03.03.02 Ombitasvir/ paritaprevir/ ritonavir Viekirax®
02.12 Omega-3-Acid Ethyl Esters Omacor®

Restricted Item Information on restriction - Dermatology only - polymorphic light eruption.


Not for hypertriglyceridaemia or secondary prevention following myocardial infarction.


 


 

02.12 Omega-3-Marine Triglycerides Maxepa®

Restricted Item Information on restriction - Dermatology only - polymorphic light eruption.


Not for hypertriglyceridaemia or secondary prevention following myocardial infarction.

01.03.05 Omeprazole 

Avoid 40mg capsules in primary care (2x20mg is more cost effective)

NHS England low value medication

A prescription for mild infrequent indegestion and heartburn should not routinely be offered in primary care as the condtion is appropriate for self-care

01.03.05 Omeprazole Losec®

Dispersible tablets for paediatrics only

01.03.05 Omeprazole IV 

As per Trust guideline

06.01.01.03 Omnican Fine 

Only 32 gauge

06.01.01.03 Omnican Lance Soft Lancets 
04.06 Ondansetron 

Zofran MELTS are non formulary

06.01.06 One Touch Select Plus® 

Category 1 preferred

06.01.06 One Touch Verio ® 

Category 2

04.09.01 Opicapone Ongentys®

Second-line after Entacapone following consultant clinician decision.

06.01.06 Oral glucose tolerance test Rapilose® OGTT

Diabetes Centre only - alternative to Polycal.

09.02.01.02 Oral Rehydration Salts 

Rapolyte is most cost effective brand in primary care

NHS England low value medicine

A prescription for treatment of acute diarrhoes should not routinely be offered in primary care as the condition is appropriate for self care

04.05.01 Orlistat 
04.09.02 Orphenadrine 

Orphenadrine tablets have been discontinued. An oral solution 50mg in 5ml is still available.

05.03.04 Oseltamivir Tamiflu®
08.02.04 Osimertinib Tagrisso
08.01.05 Oxaliplatin 
20 Oxandrolone tablets 2.5 mg 

Unlicensed


Paediatrics only

04.08.01 Oxcarbazepine Trileptal®

MHRA advice on switching:

 

Category 2: need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

11.07 Oxybuprocaine unit dose eye drops Minims®
07.04.02 Oxybutynin 

Standard (non-modified release) tablets are not suitable for the elderly, especially if frail


Avoid liquid - unlicensed specials are HIGH COST in primary care

07.04.02 Oxybutynin Hydrochloride Kentera®

Primary care only


Option for people who cannot tolerate oral antimuscarinics (NICE CG 171)

04.07.02 Oxycodone 

Palliative care second line if intolerant of morphine.  Option for post operative pain if morphine causes hallucinations (acute pain team only - to be supplied as TTO if necessary but not to be continued in primary care).

 

Most cost effective brands in primary care are Shortec (IR) and Longtec (MR)/ Oxeltra (MR)

04.07.02 Oxycodone 

Option for post-operative pain in enhanced recovery pathways

04.07.02 Oxycodone/naloxone Targinact®

Consultant gastroenterologist only for patients with opioid induced intestinal  failure requiring parenteral nutrition.  Not for general prescribing in severe pain.

05.01.03 Oxytetracycline 

First line for acne

13.06.02 Oxytetracycline tablets 
07.01.01 Oxytocin Syntocinon®
09.06.02 Pabrinex® IM and IV

Parenteral vitamins B and C for rapid correction of severe depletion or malabsorption

08.01.05 Paclitaxel 
08.01.05 Paclitaxel - Albumin Bound Formulation Abraxane®
08.03.04.01 Palbociclib  Ibrance®

Approved in accordance with NICE TA495, in combination with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.

04.02.02 Paliperidone palmitate  Trevicta®

3-monthly depot


Southern Health NHS FT and Solent NHS Trust psychiatrists only

04.02.02 Paliperidone palmitate  Xeplion®

1-monthly depot


Southern Health NHS FT and Solent NHS Trust psychiatrists only

05.03.05 Palivizumab Synagis®

Commissioned by NHSE according to JCVI and PHE guidance

01.09.04 Pancreatin Creon® 40000
01.09.04 Pancreatin Creon® Micro
01.09.04 Pancreatin Creon® 25000
01.09.04 Pancreatin Nutrizym®
01.09.04 Pancreatin Creon® 10000
15.01.05 Pancuronium bromide 
08.01.05 Panitumumab Vectibix®
08.01.05 Panobinostat Farydak®
04.07.02 Papaveretum 

Severe pain

20 Papaverine hydrochloride injection 
04.07.01 Paracetamol 

Mild to moderate pain

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

04.07.01 Paracetamol and codeine Co-codamol 8/500

Mild to moderate pain

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

04.07.01 Paracetamol and codeine Co-codamol 30/500

Severe pain.  Most cost effective brand in primary care is Zapain

04.07.01 Paracetamol and dihydrocodeine 

Mild to moderate pain

NHS England low value medication

A prescription for the treatment of minor conditions associated with pain, discomfort and mild fever should not routinely be offered in primary care as the condition is appropriate for self-care. (e.g aches and sprains, headache, period pain, back pain).

04.07.01 Paracetamol IV Perfalgan®
04.08.02 Paraldehyde Rectal Soln 

Paediatrics only, unlicensed special

09.06.07 Paravit-CF 

Fat-soluble vitamin supplements for use when recommended by specialist in patients with cystic fibrosis.

15.01.04.02 Parecoxib Dynastat®

Short term use for post-operative pain as an adjunct to opioid analgesia where oral and rectal administration is not possible (Acute Pain Consultant only)


Post-operative ileus (colorectal ERP).

09.03 Parenteral Nutrition (TPN or PN) 

Seek specialist advice on prescribing

09.06.04 Paricalcitol Zemplar®

Existing shared care patients may continue to get supplies via the GP

04.03.03 Paroxetine 

Not first line agent.  More frequent withhdrawal reactions.  Do not exceed recommended dose.  See CSM Warnings


 

09.02.01.01 Patiromer Valtassa®
08.01.05 Pazopanib Votrient®
14.04 Pediacel® 

Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)


 

08.01 Pegaspargase Oncaspar®
08.02.04 Peginterferon Alfa Pegasys®
10.02.01 Peginterferon beta 1a Plegridy®
08.01.05 Pembrolizumab Keytruda®
08.01.03 Pemetrexed 
10.01.03 Penicillamine tablets 
18 Penicillamine tablets 
05.04.08 Pentamidine Isetionate Pentacarinat®
07.04.03 Pentosan polysulfate sodium capsules  Elmiron®
20 Pentoxifylline tablets 

Alcoholic hepatitis - unlicensed use

01.02 Peppermint Oil Mintec®

Preferred brand in primary care

01.02 Peppermint Oil Colpermin®

Preferred brand in primary care is Mintec

01.01.02 Peptac 

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

04.08.01 Perampanel Fycompa®

Consultant neurologist only.

 

MHRA advice on switching:

 

Category 2: need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

06.01.06 Performa Test Strips® 

Category 1 preferred

02.05.05.01 Perindopril erbumine or tert-butylamine 
13.10.04 Permethrin 5% Lyclear® Dermal Cream

for scabies and crablice

08.01.05 Pertuzumab Perjeta®
04.07.02 Pethidine 

Severe pain

04.03.02 Phenelzine Nardil®

Psychiatry only

04.08.01 Phenobarbital 

Includes tablets and elixir.


Unlicensed alcohol-free liquid formulations may be prescribed in paediatrics.


MHRA Advice on switching:


Category 1: ensure patient is maintained on a specific manufacturer's product. 

13.11.05 Phenol 2% w/w in compound zinc paste BP 

Inlcuded on BAD specials list 2014

02.05.04 Phenoxybenzamine Hydrochloride 

Hypertension in phaeochromocytoma

05.01.01.01 Phenoxymethylpenicillin 
02.05.04 Phentolamine Rogitine®, Regitin®

Critical Care only

18 Phentolamine injection 
11.05 Phenylephrine hydrochloride unit dose eye drops Minims®
02.07.02 Phenylephrine injection 
04.07.03 Phenytoin 
04.08.01 Phenytoin 

Includes capsules, tablets, chewable tablets and suspension.


MHRA Advice on switching:


Category 1: ensure patient is maintained on a specific manufacturer's product. 


 

04.08.02 Phenytoin Injection 
03.09.01 Pholcodine Linctus, BP 

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

09.05.02.01 Phosphate Polyfusor® 
09.05.02.01 Phosphate supplements Phosphate-Sandoz®
01.06.04 Phosphates (Rectal) 
09.06.06 Phytomenadione  Konakion® MM
09.06.06 Phytomenadione Konakion® MM Paediatric

Can also be administered by mouth for high INRs in patients on warfarin.

18 Phytomenadione Vitamin K1
01.06.05 Picolax® sodium picosulfate with magnesium citrate
11.06 Pilocarpine 
12.03.05 Pilocarpine hydrochloride Salagen®
13.05.03 Pimecrolimus 1% cream Elidel®

Second line after topical steroids for moderate atopic eczema, especially face and neck - NICE TA 82. Not for children under 2 years

04.02.01 Pimozide Orap®
06.01.02.03 Pioglitazone Actos®
06.01.02.03 Pioglitazone and Metfomin Competact®

For patients established on both agents

05.01.01.04 Piperacillin and Tazobactam 

Refer to Microguide

04.02.02 Pipotiazine Palmitate Piportil® Depot

Psychiatry only

04.08.01 Piracetam Nootropil®
20 Pirenzepine tablets 
03.11 Pirfenidone Esbriet®
05.01.01.05 Pivmecillinam Selexid®
08.01.02 Pixantrone 
04.07.04.02 Pizotifen 
01.06.05 Plenvu® 
14.04 Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Prevenar 13®

For use in routine immunisation programme, at 8 weeks old, 16 weeks old and 1 year old.


Additional vaccine for individuals with underlying medical conditions (under 2 years of age)

14.04 Pneumococcal polysaccharide vaccine (23-valent) 

For use in routine immunisation programme at age 65


Additional vaccine for individuals with underlying medical conditions (from 2 years of age)

13.07 Podophyllotoxin Condyline®

GUM only

13.07 Podophyllotoxin Warticon®

GUM only

11.03.01 Polihexanide 0.02% 

Unlicensed

14.04 Poliomyelitis Vaccine Live (oral)  
06.01.06 Polycal® 

Secondary Care Only

19.20 Polyfield Nitrile Patient Pack Sterile dressing pack

Sterile dressing pack containing powder-free nitrile gloves, laminate sheet, 7 non-woven swabs, towel, apron and disposable bag.

14.04 Polysaccharide Typhoid Vaccine 

Typherix, Typhim


For adults and children over 2 years travelling to at risk areas

09.02.01.01 Polystyrene Sulphonate Resins Calcium Resonium®

For oral or rectal administration

09.02.01.01 Polystyrene Sulphonate Resins Resonium A®

For oral or rectal administration

13.09 Polytar® shampoo Coal tar solution 4%
11.08.01 Polyvinyl alchohol 1.4% eye drops SnoTears®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

08.02.04 Pomalidomide Imnovid®
08.01.05 Ponatinib Iclusig®
03.05.02 Poractant Alfa Curosurf®

Neonatal unit only

05.02 Posaconazole (IV) Noxafil®
05.02 Posaconazole (oral) Noxafil®
11.99.99.99 Potassium Ascorbate 10% (Ascorbic acid) 

Unlicensed

09.02.01.03 Potassium Bicarbonate 

Potassium bicarbonate 500 mg, potassium acid tartrate 300 mg, each tablet providing 6.5 mmol of K+.


NB these tablets do not contain chloride.

20 Potassium canrenoate injection 200 mg in 10mL 

Unlicensed


Paediatrics only

09.02.01.01 Potassium Chloride Sando-K®

Potassium bicarbonate and chloride equivalent to potassium 470 mg (12 mmol of K+) and chloride 285 mg (8 mmol of Cl-) per tablet

09.02.01.01 Potassium Chloride Slow-K®

Avoid unless effervescent tablets or liquid preparations inappropriate

09.02.01.01 Potassium Chloride Kay-Cee-L®

Potassium chloride 7.5% (1 mmol/mL each of K+ and Cl-)

09.02.02.01 Potassium Chloride and Glucose Intravenous Infusion  
09.02.02.01 Potassium Chloride and Sodium Chloride Intravenous Infusion 
09.02.02.01 Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion 
07.04.03 Potassium Citrate 

NHS England low value medicine

A prescription for treatment of mild cystitis should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

09.05.02.01 Potassium dihydrogen phosphate  
20 Potassium iodide capsules 
13.11 Potassium Permanganate Permitabs®

For preparation of topical solution, potassium permanganate 400 mg (1 tablet)dissolved in 4 litres of water provides a 0.01% (1 in 10 000) solution

13.11.06 Potassium Permanganate Permitabs®

For preparation of topical solution, potassium permanganate 400 mg (1 tablet)dissolved in 4 litres of water provides a 0.01% (1 in 10 000) solution

13.11.06 Potassium Permanganate Permitabs®

For preparation of topical solution, potassium permanganate 400 mg (1 tablet)dissolved in 4 litres of water provides a 0.01% (1 in 10 000) solution

19.20 Potassium permanganate tablets Permitabs® tablets for topical solution

Restricted Item Information on restriction - Dermatology only.


One Permitabs solution tablet should be dissolved in four litres of water to produce a 0.01% (1 in 10 000) solution of potassium permanganate.

13.11.04 Povidone-Iodine Betadine® or Videne®

Aqueous solution 10%, alcoholic solution 10% , sugical scrub 7.5%, powder spray 2.5%

18 Pralidoxime chloride Protopam®
04.09.01 Pramipexole 

NOT for restless legs syndrome.

Cost effecive brand for prescribing in primary care is Pipexus.

02.09 Prasugrel Efient®

Acute Coronary Syndromes with percutaneous coronary intervention.

02.12 Pravastatin  

Prescribe generically

01.05.02 Prednisolone 

Includes rectal foam, retention enema and suppositories

06.03.02 Prednisolone 

Plain tablets are preferred for all indications. There is no conclusive evidence that the use of enteric-coated preparations of prednisolone reduces the risk of peptic ulceration (BNF) and absorption from EC tablets may be less predictable.


Soluble tablets are very HIGH COST (£52.75 for 30, June 2017 Drug Tariff). Plain tablets can be dispersed in water (unlicensed use).

11.04.01 Prednisolone 0.5% eye drops Predsol ®
11.04.01 Prednisolone 0.5% preservative free eye drops 
11.04.01 Prednisolone 1% eye drops  Pred Forte®
12.01.01 Prednisolone ear drops Predsol®
04.02.03 Pregabalin 
04.07.03 Pregabalin 

Secondline if gabapentin effective but not tolerated.  Pain Clinic, Diabetology, Neurology Consultant only in PHT.  Refer to Chronic Pain Guidelines.

A2.01 Pregestimil Lipil®  

On advice of secondary care only

 

Cows milk allergy with malabsorption

15.02 Prilocaine Hydrochloride Citanest®
15.02 Prilocaine Hydrochloride Prilotekal®

Spinal anaesthesia in day surgery patients only

15.02 Prilocaine Hydrochloride with Felypressin Citanest with Octapressin®
05.04.01 Primaquine 
04.08.01 Primidone 

Note HIGH COST in primary care.

 

MHRA Advice on switching:

 

Category 1: ensure patient is maintained on a specific manufacturer's product. 

14.04 Priorix®  

Measles, Mumps and Rubella vaccine (live)


For use in routine immunisation programme at 1 year old and preschool booster

08.01.05 Procarbazine 
04.06 Prochlorperazine 
04.06 Prochlorperazine Buccastem®
04.09.02 Procyclidine 
04.09.02 Procyclidine 
18 Procyclidine 

Treatment of poisoning - dystonic reactions

13.10.05 Proflavine Cream, BPC  
06.04.01.02 Progesterone Crinone®

4% Gel

 

Secondary care intiated - see IVF protocol

06.04.01.02 Progesterone Cyclogest®

Under secondary care supervision - recurrent miscarriage (unlicensed)

06.04.01.02 Progestogen (micronised) oral/ vaginal capsules Utrogestan ®

Only 100mcg capsules are licensed for HRT

 

Can be administered orally or vaginally

08.02.02 Prograf® Tacrolimus
08.02.02 Prograf® Tacrolimus

RED for renal indications

05.04.01 Proguanil Hydrochloride Paludrine®

Travel Prophylaxis - Private Prescription

05.04.01 Proguanil Hydrochloride with Atovaquone Malarone®

Travel Prophylaxis - Private Prescription

05.04.01 Proguanil hydrochloride with chloroquine 

Travel prophylaxis - private prescription

04.02.01 Promazine Hydrochloride 
03.04.01 Promethazine Phenergan®

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

04.06 Promethazine Hydrochloride Phenergan

NHS England low value medication

A prescription for the treatment of travel sickness should not routinely be offered in primary care as the condition is appropriate for self-care.

02.03.02 Propafenone 
11.03.01 Propamidine Isetionate Brolene® eye drops

Acanthamoeba keratitis (unlicensed indication)

15.01.01 Propofol Diprivan®
02.04 Propranolol 
04.07.04.02 Propranolol 
20 Propylene glycol 40% w/w in aqueous cream 

Unlicensed special listed on BAD specials list 2018

13.04 Propylene glycol 40% w/w in Dermovate cream 

Included in BAD specials list 2014

20 Propylene glycol 50% w/w in water 

Unlicensed special listed on BAD specials list 2018

13.02.01 Propylene gycol 20% w/w in aqueous cream 

Included on BAD special list

06.02.02 Propylthiouracil 
02.08.03 Protamine sulfate injection 
18 Protamine Sulphate 

Heparin overdose / reversal

02.11 Prothrombin Complex Concentrate  Octaplex®
19.15 Protosan 30ml gel 

Cleansing, decontamination and moisturising of acute and chronic skin wounds, first and second degree burns. (impregnated with dialkylcarbamoyl chloride)

19.15 Protosan 350ml bottle 

Single patient use, more cost effective and has a shelf life of 8 weeks once opened.


Wound irrigation solution containing Betaine which is gentle effective surfactant which penetrates, disturbs and removes biofilm and wound debris, and PHMB to help control bacterial levels on the wound.

19.15 Protosan 40ml Pod 

Protonsan pods should be reserved for acute use only.

11.07 Proxymetacaine unit dose eye drops Minims®
01.06.07 Prucalopride Resolor®

Refractory constipation in women only in line with NICE TA 211

03.10 Pseudoephedrine Hydrochloride Galpseud®

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

05.01.09 Pyrazinamide 

Oral solution 500mg in 5ml (unlicensed) for use in paediatrics only

10.02.01 Pyridostigmine Bromide 
18 Pyridoxine 50mg/mL 

Neonatal unit - for seizures caused by inborn errors of metabolism.


Isoniazid poisoning

09.06.02 Pyridoxine hydrochloride 
05.04.01 Pyrimethamine with Sulfadoxine Fansidar®
04.02.01 Quetiapine 

Immediate release only

04.02.01 Quetiapine XL 

Generic immediate release tablets are first line - refer to guidance from Solent NHS Trust and Southern Health NHS FT

 

Most cost effective brand in primary care is Sondate XL

06.07.01 Quinagolide Norprolac®

Hyperprolactinaemia - safer alternative to cabergoline

10.02.02 Quinine bisulphate tablets 

For nocturnal cramps

05.04.01 Quinine dihydrochloride 

Available from special order manufacturers or specialist importers

05.04.01 Quinine sulfate 
13.02.01 QV® 

Suitable for twice daily use

14.04 Rabies vaccine 

Private supply only

08.03.04.02 Radium-223 dichloride Xofigo®
06.04.01.01 Raloxifene Hydrochloride Evista®
05.03.01 Raltegravir Isentress ®

HIV infection only

08.01.03 Raltitrexed Tomudex®
02.05.05.01 Ramipril 
11.08.02 Ranibizumab Lucentis®
01.03.01 Ranitidine 

Includes tablets, oral solution and injection

NHS England low value medication

A prescription for mild infrequent indegestion and heatburn should not routinely be offered in primary care as the condtion is appropriate for self-care

02.06.03 Ranolazine Ranexa®
04.09.01 Rasagiline 
10.01.04 Rasburicase Fasturtec®

Oncology, Haematology and Crtical Care only

13.08.01 Reflectant (Dundee) sunscreens  

coffee, coral pink, beige

 

Used to treat photosensitivity disorders where the patient is sensitive to visible light, most commonly solar urticaria and porphyrias, particularly erythropoietic protoporphyria.

 

Unlicensed specials on BAD list

 

 

08.01.05 Regorafenib Stivarga®
15.01.04.03 Remifentanil 

Critical Care only

06.01.02.03 Repaglinide Prandin®

Secondary Care initiated

 

Alternative to sulphonylurea in selected patients

14.04 Repevax® 

Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)


For use in routine immunisation programme - preschool booster

03.04.02 Reslizumab Cinquaero®
14.04 Revaxis® 

Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)


For use in routine childhood vaccination programme - teenage booster

05.03.05 Ribavirin 

RSV bronchiolitis - consultant paediatrician only

08.03.04.01 Ribociclib  Kisqali®

Approved in accordance with the Cancer Drugs Fund and NICE TA496 in combination with an aromatase inhibitor for the treatment of postmenopausal woman with previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.

05.01.09 Rifabutin Mycobutin®

Mycobacterium avium prophylaxis only

05.01.09 Rifampicin Rifadin®
05.01.09 Rifampicin and Isoniazid Rifinah®
05.01.09 Rifampicin and Isoniazid and Pyrazinamide Rifater®
05.01.09 Rifampicin, isoniazid, pyrazinamide and ethambutol Voractiv®
05.01.07 Rifaximin Targaxan®

Hepatic encephalopathy, consultant hepatologist only

05.03.01 Rilpivirine hydrochloride Edurant®

HIV infection only

05.03.01 Rilpivirine, emtrictabine and tenofovir alafenamide Odefsey®

HIV infection only

04.09.03 Riluzole 
13.05.03 Risankizumab Skyrizi®
06.06.02 Risedronate sodium 

Second-line for Paget's disease

06.06.02 Risedronate sodium 

Once weekly for osteoporosis

04.02.01 Risperidone 
04.02.02 Risperidone Risperdal Consta®

Southern Health NHS FT and Solent NHS Trust psychiatrists only

05.03.01 Ritonavir Norvir®

HIV infection only

08.02.03 Rituximab MabThera®

Lymphoma only. NHSE SSC 1434

08.02.03 Rituximab MabThera®, Truxima®
10.01.03 Rituximab MabThera®, Truxima®

For SLE refer to NHSE policy

02.08.02 Rivaroxaban Xarelto®

 VTE following elective hip and knee replacement - FULL COURSE SUPPLIED BY HOSPITAL

02.08.02 Rivaroxaban Xarelto®

Stroke prevention in non-valvular AF


DVT treatment and secondary prevention


PE treatment and secondary prevention

02.08.02 Rivaroxaban Xarelto®

Post ACS with antiplatelet

04.11 Rivastigmine 

Alzeimers Disease

Dementia associated with Parkinsons disease or Lewy bodies - Priorities Committee Policy Statement 25

 Cost effective brand for prescribing in primary care is Alzest

 

04.07.04.01 Rizatriptan tablets, orodispersible tablets
15.01.05 Rocuronium bromide 
03.03.03 Roflumilast Daxas®
09.01.04 Romiplostim Nplate®
04.09.01 Ropinirole 

Can be used for Parkinson's Disease, restless legs syndrome if initiated by Sleep Clinic or symptom control in renal palliative care (off-license).  MR formulation may improve adherence

Cost effective brand for primary care is Spiroco or Ipinnia

15.02 Ropivacaine Hydrochloride Naropin®
02.12 Rosuvastatin 

Third-line only if other statins cannot be tolerated

14.04 Rotavirus vaccine Rotarix®

For use in routine immunisation programme at 8 weeks old and and 12 weeks old.

04.09.01 Rotigotine Neupro®
08.01.05 Rucaparib Rubraca®
04.08.01 Rufinamide Inovelon®

Adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome - initiation by paediatric neurology specialist only.

 

MHRA advice on switching:

 

Category 2: need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

08.01.05 Ruxolitinib Jakavi®
02.05.05.02 Sacubitril valsartan Entresto®

Symptomatic chronic heart failure with reduced ejection fraction NICE TA 388

03.01.01.01 Salbutamol 

Nebuliser solution

03.01.01.01 Salbutamol Easyhaler

Cost-effective option when a dry powder device is required

03.01.01.01 Salbutamol Ventolin®

MDI / Accuhaler

03.01.01.01 Salbutamol Asmasal Clickhaler®

Dry powder

03.01.01.01 Salbutamol Salamol®Easi-Breathe
07.01.03 Salbutamol infusion unlicensed
03.01.01.01 Salbutamol IV 
13.07 Salicylic acid 12% gel Salatac®

NHS England low value medication

A prescription for the treatment of warts and verrucae should not routinely be offered in primary care as the condition is appropriate for self-care.

13.07 Salicylic acid 16.7% with lactic scid 16.7% Salactol®

NHS England low value medication

A prescription for the treatment of motion sickness should not routinely be offered in primary care as the condition is appropriate for self-care.

13.05 salicylic acid 2% w/w and sulphur 2% w/w in aqueous cream 

Included in BAD specials list 2014

13.07 Salicylic acid 26% Occlusal®

NHS England low value medication

A prescription for the treatment of warts and verrucae should not routinely be offered in primary care as the condition is appropriate for self-care.

13.04 Salicylic acid 5% w/w / propylene glycol 47.5% w/w in Dermovate cream 

Included on BAD specials list 2014

03.01.01.01 Salmeterol 

MDI


Accuhaler


 

09.06.07 Sanatogen® A-Z Complete  

Adults only where a combination of vitamins and minerals is required.

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

09.05.01.01 Sandocal-1000® 

Calcium 1g = 25mmol per tablet

05.03.01 Saquinavir Invirase®

HIV infection only

10.01.03 Sarilumab  Kevzara®

For use in line with NICE TA485 

13.05.02 Sebco® 
10.01.03 Secukinumab injection Cosentyx®
13.05.03 Secukinumab injection Cosentyx®
04.09.01 Selegiline Hydrochloride 
06.01.02.03 Semaglutide Ozempic®

Once weekly injection for type 2 diabetes

01.06.02 Senna 

Includes tablets and syrup

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

04.03.03 Sertraline 

First line agent in general population

09.05.02.02 Sevelamer Carbonate Renvela®

Red for renal dialysis patients

09.05.02.02 Sevelamer Hydrochloride  Renagel®

Red for renal dialysis patients

15.01.02 Sevoflurane 
02.05.01 Sildenafil Revatio®

Pulmonary Hypertension in paediatrics

07.04.05 Sildenafil 

First line for erectile dysfuntion


NHS prescribing unrestricted for generic

13.02.02 Silicone Sterile barrier cream 
13.07 Silver nitrate 40% with potassium nitrate 60% AVOCA®
13.07 Silver nitrate 95% with potassium nitrate 5% AVOCA®
13.10.01.01 Silver Sulfadiazine cream Flamazine®
01.01.01 Simeticone Infacol®

NHS England low value medicine

A prescription for treatment of infant colic should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

A2.01 Similac Alimentum 

Cows Milk Protein Allergy

 

Extensively Hydrolysed Formula

 

First Choice Agent

A2.01 Similac High Energy 

See faltering growth guideline

03.09.02 Simple Linctus, BP 

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

02.12 Simvastatin 

Prescribe generically

13.02.02 Siopel® barrier cream 
08.02.02 Sirolimus Rapamune®

Existing patients with shared care may continue to obtain supplies via GP.

20 Sirolimus 0.1% in WSP 

Unlicensed special listed on BAD specials list 2018

20 Sirolimus 0.5% in WSP 

Unlicensed special listed on BAD specials list 2018

06.01.02.03 Sitagliptin Januvia®

 


 

A2.01 SMA Alfamino 

Cows Milk Protein Allergy 2nd line

First line for anaphylactic reaction/severe reations

 

A2.01 SMA Alfamino ® 

Amino Acid Formula

 

First line for severe reactions/ anaphylactic reactions/ reactions to breast milk

 

Refer to secondary care

A2.01 SMA Althera 

Extensively Hydrolysed Formulae - CMPA

A2.01 SMA High Energy 

See faltering growth guidance

A2.01 SMA Pro Gold Prem 2 

Should not be initiated in primary care

 

Follow hospital discharge instructions

Ensure review at 6 months corrected age

A2.01 SMA Pro High Energy® 

Energy dense formula

09.03 SMOF lipid® 
09.05.02 Sodium acid phosphate 1mmol in 1ml 

Paediatrics only


Unlicensed special

10.01.03 Sodium aurothiomalate Myocrisin®

Manufacturer reports that this product is being discontinued in 2019

09.08.01 Sodium benzoate 2g in 10ml injection 

Unlicensed special

 

Paediatrics only

09.02.01.03 Sodium Bicarbonate 

Sodium bicarbonate 500mg  approx. 6 mmol each of Na+ and HCO3– 

09.02.02.01 Sodium Bicarbonate 
18 Sodium bicarbonate 

Treatment of poisoning

12.01.03 Sodium bicarbonate ear drops 

NHS England low value medication

A prescription for the removal of earwax should not routinely be offered in primary care as the condition is appropriate for self-care.

09.02.02.01 Sodium bicarbonate oral solution 8.4% 1mmol in 1ml 

Unlicensed special

 

Paediatrics only

09.02.01.02 Sodium Chloride Slow Sodium®

Sodium chloride 600 mg (approx. 10 mmol each of Na+ and Cl-) per modified release tablet. 

13.11.01 Sodium Chloride 0.9% 
09.02.01.02 Sodium chloride 29.2% oral solution  

Paediatrics only

03.07 Sodium chloride 3% (Hypertonic) MucoClear®

Paediatrics only – bronchiolitis

11.08.01 Sodium Chloride 5% eye drops and ointment 
03.07 Sodium chloride 7% (Hypertonic) 

Cystic fibrosis - adults and children. Refer to Drug Tariff for products prescribable on FP10

09.02.02.01 Sodium Chloride and Glucose Intravenous Infusion 
09.02.02.01 Sodium chloride intravenous injection/infusion 
01.06.04 Sodium Citrate Relaxit, Micolette
11.99.99.99 Sodium citrate preservative free 

Unlicensed

03.03.01 Sodium Cromoglicate Intal®

MDI

11.04.02 Sodium cromoglicate 2% eye drops 

NHS England low value medication

A prescription for the treatment of mild to moderate hay fever should not routinely be offered in primary care as the condition is appropriate for self-care

09.01.01.01 Sodium Feredetate Sytron®
09.05.03 Sodium fluoride mouthwash 0.05% En-De-Kay®

On formulary for mouthcare for patients undergoing chemotherapy and/or radiotherapy only.

Refer to PHT guidance on mouthcare for patients undergoing chemotherapy and/or radiotherapy.

 

NHS England low value medication

A prescription for high fluoride toothpaste/mouthwash should not routinely be offered in primary care as the condition is appropriate for self-care

09.05.03 Sodium fluoride mouthwash 0.05% FluoriGard®

Available as an alcohol-free formulation.

On formulary for mouthcare for patients undergoing chemotherapy and/or radiotherapy only.

Refer to PHT guidance on mouthcare for patients undergoing chemotherapy and/or radiotherapy.

 

NHS England low value medication

A prescription for high fluoride toothpaste/mouthwash should not routinely be offered in primary care as the condition is appropriate for self-care

09.05.03 Sodium fluoride toothpaste  Duraphat®

2800ppm (0.619%) and 5000ppm (1.1%) sodium fluoride

 

Red      Solent and Southern Health long stay inpatients only following dental assessment.

 

Patients receiving radiotherapy to the head and neck, following dental asessment (refer to PHT mouth care guidelines for patients undergoing chamotherapy and/or radiotherapy)

 

NHS England low value medication

A prescription for high fluoride toothpaste/mouthwash should not routinely be offered in primary care as the condition is appropriate for self-care

05.01.07 Sodium fusidate Fucidin®
13.10.01.02 Sodium fusidate 2% ointment Fucidin®
11.08.01 Sodium hyaluronate 0.1% eye drops Hylo-Tear®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

11.08.01 sodium hyaluronate 0.15% eye drops  Artelac Rebalance®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

11.08.01 Sodium hyaluronate 0.2% eye drops Hylo-Forte®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

11.08.01 Sodium hyaluronate 0.4% eye drops and unit dose eye drops Clinitas®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

11.08.02 Sodium hyaluronate 1% in 1ml Z-Hyalin®
20 Sodium Hyaluronate 800mg/50mL (1.6%), Sodium Chondroitin Sulfate 1g/50mL (2%) iAluRil®

Licensed as a medical device


Urology only

11.08.01 Sodium hyaluronate with dexpanthenol 2% eye drops Hylo-Care®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

01.06.02 Sodium hydrogen carbonate 0.5g/ sodium dihydrogen phosphate 0.68g Lecicarbon A®

Gastroenterology or urogynaecology recommendation for chronic constipation in adults that has not been successfully managed with standard laxatives, particularly where there are problems with evacuation.

13.11.04 Sodium Hypochorite Solution 1% Milton®
18 Sodium nitrite 

Antidote for cyanide poisoning


Available as Nithiodote (Co-Packaged Sodium Nitrite 30 mg/mL Solution for Injection and Sodium Thiosulfate 250 mg/mL Solution for Injection)

02.05.01 Sodium nitroprusside 

Critical Care Only

09.08.01 Sodium phenylbutyrate 2g in 10ml 

Unlicensed

01.06.02 Sodium Picosulfate 

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

02.13 Sodium Tetradecyl Sulphate Fibro-Vein®
18 Sodium thiosulfate  

Antidote for cyanide poisoning


Available as Nithiodote (Co-Packaged Sodium Nitrite 30 mg/mL Solution for Injection and Sodium Thiosulfate 250 mg/mL Solution for Injection)

20 Sodium thiosulfate  

Calciphylaxis

04.02.03 Sodium valproate 
04.08.01 Sodium Valproate 

Includes tablets, MR tablets and liquid


MHRA advice on switching:


Category 2 - need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

04.08.01 Sodium Valproate injection 
09.02.01.01 Sodium zirconium cyclosilicate Lokelma®

Secondary care prescribing only as PAS pricing

05.03.03.02 Sofosbuvir Sovaldi®
05.03.03.02 Sofosbuvir/velpatasvir Epclusa®
05.03.03.02 sofosbuvir/velpatasvir/voxilaprevir  Vosevi®
19.01 Softpore 10cm x 10cm 

Not to be used on fragile skin. For minor superficial wounds where all that is required is protection from friction. can be used post-op which can stay in place for 3-5 days.

19.01 Softpore 10cm x 15cm 

Not to be used on fragile skin. For minor superficial wounds where all that is required is protection from friction. can be used post-op which can stay in place for 3-5 days.

19.01 Softpore 10cm x 20cm 

Not to be used on fragile skin. For minor superficial wounds where all that is required is protection from friction. can be used post-op which can stay in place for 3-5 days.

19.01 Softpore 10cm x 25cm 

Not to be used on fragile skin. For minor superficial wounds where all that is required is protection from friction. can be used post-op which can stay in place for 3-5 days.

19.01 Softpore 10cm x 30cm 

Not to be used on fragile skin. For minor superficial wounds where all that is required is protection from friction. can be used post-op which can stay in place for 3-5 days.

19.01 Softpore 6cm x 7cm 

Not to be used on fragile skin. For minor superficial wounds where all that is required is protection from friction. can be used post-op which can stay in place for 3-5 days.

07.04.02 Solifenacin Vesicare®
06.05.01 Somatropin Injection
08.01.05 Sorafenib Nexavar®
06.01.02.03 Sotagliflozin 

For use by the hospital diabetes team only

02.04 Sotalol 
07.03.03 Spermicidal Contraceptives Gygel gel

To be used in conjunction with another method

02.02.03 Spironolactone 50mg in 5ml 

Unlicensed special listed in Drug Tariff

 

Paediatrics only

02.02.03 Spironolactone tablets 
13.02.02 Sprilon® spray 
05.03.01 Stavudine Zerit®

HIV infection only

01.06.01 Sterculia Normacol®

NHS England low value medication

A prescription for infrequent constipation should not routinely be offered in primary care as the condtion is appropriate for self-care

09.06.04 Stexerol-D3® 25,000 units 

Colecalciferol 25,000 units per tablet


Tablets can be swallowed whole or crushed.

09.06.04 Stexerol-D3® 1,000 units 

Colecalciferol 1,000 units per tablet


Tablets can be swallowed whole or crushed.

04.08.01 Stiripentol Diacomit®

For Adults a shared care guideline is awaited

For paediatric patients, Stiripentol is Amber Initiated 

01.08 Stoma Care 

Products will be recommended by stoma care nurses

02.10.02 Streptokinase 

Restricted Item Information on restriction - CCU, A&E and Surgery only

01.03.03 Sucralfate 

Includes tablets and suspension

20 Sucralfate 4% in emulsifying ointment 

Unlicensed special listed on BAD specials list 2018

09.05.02.02 sucroferric oxyhydroxide Velphoro®

For management of hyperphosphataemia in adult patients on dialysis only.

13.02.02 Sudocrem® cream 

NHS England low value medication

A prescription for the treatment of nappy rash should not routinely be offered in primary care as the condition is appropriate for self-care

15.01.06 Sugammadex Bridion®

For emergency reversal of rocuronium following failed intubation - refer to PHT Drug Therapy Guideline

01.05.01 Sulfasalazine 

Includes tablets and suspension

10.01.03 Sulfasalazine EC Salazopyrin EN-Tabs®

Initiation by rheumatologist only

 

Salazopyrin brand most cost effective in primary care

04.02.01 Sulpiride 
04.07.04.01 Sumatriptan 

Note 50mg tablets available in PHT to aid diagnosis only NOT for routine treatment

 

NHS England low value medicine

A prescription for infrequent mild migraine should not routinely be offered in primary care as the condition is suitable for self-care.

08.01.05 Sunitinib Sutent®
13.08.01 Sunsense® Ultra 

NHS England low value medicine

A prescription for sun protection should not routinely be offered in primary care as this is suitable for self-care.

Sun protection may be prescribed as per ACBS recommendations: Approved for skin protection against UV radiation in abnormal cutaneous photosensitivity. This includes genetic disorders, photodermatoses, vitiligo from radiotherapy and chronic or recurrent herpes simplex labialis.

09.03 Supplementary Preparations for intravenous nutrition 
19.08 Suprasorb A 10cm x 10cm 

Calcium alginate primary dressing for use in shallow, moist wounds. for management of moderatley or heavily exuding wounds.


secondary dressings are required to support the alginate in situ and maintain a moist environment.

19.08 Suprasorb A 5cm x 5cm 

Calcium alginate primary dressing for use in shallow, moist wounds. for management of moderatley or heavily exuding wounds.


secondary dressings are required to support the alginate in situ and maintain a moist environment.

19.08 Suprasorb A Rope 2g (30cm) 

For exudate management and wound healing of large open cavity wounds.

19.15 Suprasorb X + PHMB 14cm x 20cm 

Light to moderately exuding wounds, superficial and deep, critically colonised and infected wounds. Bio-cellulose dressing impregnated with broad-spectrum antimicrobial (PMBH polyhexamethylene biguanide 0.3%) can be effective if the wound is infected and painful.

19.15 Suprasorb X + PHMB 2cm x 21cm 

Light to moderately exuding wounds, superficial and deep, critically colonised and infected wounds. Bio-cellulose dressing impregnated with broad-spectrum antimicrobial (PMBH polyhexamethylene biguanide 0.3%) can be effective if the wound is infected and painful.

19.15 Suprasorb X + PHMB 5cm x 5cm 

Light to moderately exuding wounds, superficial and deep, critically colonised and infected wounds. Bio-cellulose dressing impregnated with broad-spectrum antimicrobial (PMBH polyhexamethylene biguanide 0.3%) can be effective if the wound is infected and painful.

19.15 Suprasorb X + PHMB 9cm x 9cm 

Light to moderately exuding wounds, superficial and deep, critically colonised and infected wounds. Bio-cellulose dressing impregnated with broad-spectrum antimicrobial (PMBH polyhexamethylene biguanide 0.3%) can be effective if the wound is infected and painful.

15.01.05 Suxamethonium chloride 
13.05.03 Tacrolimus Protopic®

0.03% and 0.1%

 

Second-line after steroids for moderate to severe atopic eczema - NICE TA 82. Not for children under 2. Age 2-16 use 0.03% only

20 Tacrolimus 0.1% and 0.03% in Orabase 

Used for ulcerative and erosive inflammatory skin disease including around stomas.

 

Unlicensed special on BAD list.

 

 

07.04.05 Tadalafil Cialis®

Second line if a longer duration of action is needed

11.06 Tafluprost (Preservative Free) 15micrograms/ml Saflutan®
11.06 Tafluprost and Timolol Taptiqom®

Preservative-free drops in single dose containers.

 

Only for use where preservative-free combination treatment is indicated.

20 TALC BP purified sterile  

For talc pleurodesis - refer to PHT Drug Therapy Guideline

08.02.04 Talimogene laherparepvac Imlygic®
08.01.05 Talimogene laherparepvec Imlygic®
08.03.04.01 Tamoxifen 
07.04.01 Tamsulosin hydrochloride 
04.07.02 Tapentadol Palexia®

Acute pain team only as alternative to oxycodone and only if first-line morphne not tolerated. To be supplied as TTO only if prescribed by acute pain team; not to be continued in primary care


 

04.07.02 Tapentadol Palexia®SR

Severe chronic pain, secondline option only when morphine has not provided adequate pain control or cannot be tolerated

 

 

13.05.02 Tazarotene  Zorac®

0.05% and 0.1% gel

08.01.03 Tegafur with Uracil Teysuno®
05.01.07 Teicoplanin Targocid®
04.01.01 Temazepam 

Short term use only

05.01.01.02 Temocillin Negaban®

On microbiology advice

08.01.05 Temozolomide 
02.10.02 Tenecteplase Metalyse®

Restricted Item Information on restriction - For myocardial infarction only - use alteplase for PE

05.03.01 Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg Atripla®

HIV infection only

05.03.01 Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya®

HIV infection only

05.03.01 Tenofovir and Emtricitabine Truvada®

HIV infection only

05.03.01 Tenofovir Disproxil Viread®
05.03.01 Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild®

HIV infection only

05.02 Terbinafine 

Dermatology use only in secondary care.

13.10.02 Terbinafine 1% cream 

NHSE low value medication

A prescription for the treatment of ringworm or athlets foot should not routinely be offered in primary care as the condition is appropriate for self-care

03.01.01.01 Terbutaline 

Turbohaler (DPI)


Nebules

06.06.01 Teriparatide Forsteo®

Secondary Care Only

06.05.02 Terlipressin Glypressin®

Secondary Care only

06.04.02 Testosterone and Esters 

Alternative injection for use by paediatrics if Sustanon is unavailable

 

Secondary care initiated

06.04.02 Testosterone and Esters Testogel®
06.04.02 Testosterone gel  Tostran®
06.04.02 Testosterone injection Sustanon 250®

 

 

 

06.04.02 Testosterone undecanoate Nebido®

3 monthly IM - alternative to sustanon

 

 

14.05.02 Tetanus immunoglobulin 
04.09.03 Tetrabenazine 
15.02 Tetracaine (Amethocaine) Ametop®
11.07 Tetracaine unit dose eye drops Minims®

0.5% and 1%

06.05.01 Tetracosactide Synacthen®

Secondary care only

05.01.03 Tetracycline 

Restricted prescribing as per Microguide or NICE prescribing guidance

03.07 Tezacaftor/Ivacaftor Symkevi®

NHS England commissioning statement Cystic Fibrosis Modular Therapies 190137P

08.02.04 Thalidomide Celgene®
03.01.03 Theophylline Nuelin® SA

Prescribe by brand name

03.01.03 Theophylline Uniphyllin® Continus

Prescribe by brand name

09.06.02 Thiamine 
A2.05.02 Thick and Easy®  
15.01.01 Thiopental sodium 
08.01.01 Thiotepa 
A2.05.02 Thixo-D®  
06.05.01 Thyrotropin Alfa Thyrogen®

Secondary care only

04.08.01 Tiagabine Gabitril®

MHRA advice on switching:

 

Category 3: usually unnecessary to ensure that patients are maintained on a specific manufacturer's product unless there are specific concerns, such as patient anxiety and risk of confusion or dosing errors.

06.04.01.01 Tibolone Livial®

Short term treatment of oestrogen deficiency

02.09 Ticagrelor Brilique®

In combination with aspirin for prevention of atherothrombotic events in ACS -  90mg bd for up to 12 months

 

In combination with aspirin in people with a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event - 60mg bd for up to 3 years

05.01.03 Tigecycline Tygacil®

Microbiology recommendation only

13.05.03 Tildrakizumab Ilumetri®
13.04 Timodine® 

Hydrocortisone 0.5%, nystatin 100 000 units/g

11.06 Timolol 0.25% and 0.5% 

Eye dops, eye gel, preservative free unit dose eye drops

05.01.11 Tinidazole Fasigyn®

GUM and H Pylori eradication only

02.08.01 Tinzaparin 

Restricted Item Information on restriction - haemodialysis only

08.01.03 Tioguanine 
03.01.02 Tiotropium Spiriva®

Handihaler and Respimat (Refer to COPD guidelines)

03.01.04 Tiotropium & olodaterol® Spiolto Respimat

LABA + LAMA refer to COPD guidelines

05.03.01 Tipranavir Aptivus®

HIV infection only

08.01.05 Tisagenlecleucel Kymriah®
08.01.05 Tivozanib Fotivda®
10.02.02 Tizanidine tablets 

Spasticity - secondline after baclofen

05.01.04 Tobramycin 
05.01.04 Tobramycin Bramitob®

Cystic fibrosis only - cycle 28 days on treatment, 28 days off.

05.01.04 Tobramycin inhaler TOBI Podhaler®

Pseudomonas lung infection in cystic fibrosis 

10.01.03 Tocilizumab RoActemra®
10.01.03 Tofacitinib  Xeljanz®
02.05.01 Tolazoline 

Paediatrics only

07.04.02 Tolterodine 
06.05.02 Tolvaptan Samsca®

Proven SIADH with failure of fluid restriction. Consultant endocrinologist only to diagnose and prescribe. Short term use only - not for TTO.


Hypomatraemia due to SIADH in patients receving cancer chemotherapy- refer to NHSE Comsssioining policy and PHT Drug Therapy Guideline

06.05.02 Tolvaptan Jinarc®

Secondary Care only


Autosomal dominant polycystic kidney disease

04.07.04.02 Topiramate 
04.08.01 Topiramate 

MHRA advice on switching:

 

Category 2 - need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

08.01.05 Topotecan 
08.01.05 Topotecan Hycamtin®
08.01.05 Trabectedin Yondelis®
04.07.02 Tramadol 

Not first line - refer to Chronic Pain Guidelines.


Immediate release preferred.  


Preferred brand of MR tablets in primary care is Tramulief (twice daily dosage) - prescribe by brand name.

04.07.02 Tramadol injection 
04.07.02 Tramadol oral solution 50mg in 5ml 

Unlicensed


Paediatrics only

08.01.05 Trametinib Mekinist®
02.11 Tranexamic Acid 
02.11 Tranexamic acid 250mg in 5ml 

Paediatrics only

 

Unlicensed special listed in Drug Tariff

04.03.02 Tranylcypromine 

Psychiatry only

 

Note HIGH  COST in primary care

08.01.05 Trastuzumab Herceptin®

Subcutaneous injection licensed for breast cancer only.

08.01.05 Trastuzumab emtansine Kadcyla®
11.06 Travoprost Travatan®
11.06 Travoprost with Timolol DuoTrav®
04.03.01 Trazodone 
03.02 Trelegy DPI 

Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed. More cost-effective than using separate ICS/LABA + LAMA.


Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms fluticasone furoate, 65 micrograms umeclidinium bromide equivalent to 55 micrograms umeclidinium and 22 micrograms vilanterol (as trifenatate). This corresponds to a pre-dispensed dose of 100 micrograms fluticasone furoate, 74.2 micrograms umeclidinium bromide equivalent to 62.5 micrograms umeclidinium and 25 micrograms vilanterol (as trifenatate).


Dose: 1 inhalation once daily

08.01.01 Treosulfan 
08.01.05 Tretinoin 
06.03.02 Triamcinolone Kenalog®
20 Triamcinolone 0.1% in Orabase  

Used for ulcerative and erosive inflammatory skin disease including around stomas.

 

 

 

Unlicensed special on BAD list.

10.01.02.02 Triamcinolone acetonide 

Adcortyl Intra-articular/Intradermal Injection 10 mg/ml


Kenalog Intra-articular / Intramuscular Injection 40mg/ml

10.01.02.02 Triamcinolone hexacetonide 20mg per ml

For intra-articular and peri-articular injection

12.01.01 Triamcinolone with Antibacterial Otocomb Otic®

Unlicensed in the UK. For ENT clinic use only.

5g tube contains:
Triamcinolone Acetonide 1mg/g
Gramicidin 0.25mg/g
Neomycin Base (as sulphate) 2.5mg/g
Nystatin in Plastibase 100,000units/g 
   

06.01.01.03 TriCare pen needles 
13.07 Trichloroacetic Acid 

Dermatology Only

13.01 Trichloroacetic acid 90% w/v 

Included in BAD specials list 2014

13.11.05 Triclosan 2% Ster-Zac Bath Concentrate®
04.02.01 Trifluoperazine 
11.03.03 Trifluorothymidine 1% 

Unlicensed - ophthalmology only

08.01.03 Trifluridine-tiparicil tablets Lonsurf®
04.09.02 Trihexyphenidyl Benzhexol
03.02 Trimbow MDI 

Beclometasone/formoterol and glycopyrronium combined inhaler.


Each delivered dose (the dose leaving the mouthpiece) contains 87 micrograms of beclometasone dipropionate, 5 micrograms of formoterol fumarate dihydrate and 9 micrograms of glycopyrronium (as 11 micrograms glycopyrronium bromide).


Dose: 2 inhalations twice daily

05.01.08 Trimethoprim 
13.04 Trimovate® 

Clobetasone butyrate 0.05%, oxytetracycline 3% (as calcium salt), nystatin 100 000 units/g,

06.07.02 Triptorelin 
08.03.04.02 Triptorelin Decapeptyl®
20 TROMETAMOL (THAM) 125ML Injection 3.6% (0.3M) 

Paediatric Use Only

11.05 Tropicamide eye drops and unit dose eye drops 

0.5 % and 1% eye drops and preservative-free unit dose eye drops (Minims)

06.01.01.03 TRUEplus Lancets 
06.01.06 TrueYou® 

Category 1 preferred

14.04 Typhoid Live Oral vaccine Vivotif®

For adults and children over 6 years travelling to at risk areas

07.03.05 Ulipristal EllaOne®

Second line on days 4 and 5 post UPSI if IUD unsuitable/not acceptable

19.23 Ultra Lite 10cm x 4.5cm 

Bandage should be used as an alternative to K-Lite where there are symptoms of, or identified arterial disease present in the lower leg.

19.23 Ultra Soft 10cm x 3.5cm 

Sub compression padding bandage used to protect the limb and for shaping if required.

03.01.02 Umeclidinium Incruse Ellipta®

Refer to COPD guidelines

03.01.04 Umeclidinium & vilanterol Anoro Ellipta®

LABA+LAMA. Refer to COPD guidelines

01.07.02 Uniroid HC 

More cost effective than Proctosedyl.  Includes ointment and suppositories

NHS England low value medicine

A prescription for treatment of haemorrhoids should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment

19.20 UrgoStart® 

There are 5 formats of the dressing and each comes in different sizes: UrgoStart Contact Layer, UrgoStart Non-Adhesive, UrgoStart Plus Pad, UrgoStart Border and UrgoStart Plus Border.

02.10.02 Urokinase 

Restricted Item Information on restriction - Only for clearing blocked catheters

07.04 Uromune® 

For prescribing on a named patient basis by Mr Hall and Miss Burton only

01.09.01 Ursodeoxycholic acid 

Includes capsules, tablets and suspension

01.05.03 Ustekinumab Stelara®
10.01.03 Ustekinumab 
13.05.03 Ustekinumab injection Stelara®
13.08.01 Uvistat® 

NHS England low value medicine

A prescription for sun protection should not routinely be offered in primary care as this is suitable for self-care.

Sun protection may be prescribed as per ACBS recommendations: Approved for skin protection against UV radiation in abnormal cutaneous photosensitivity. This includes genetic disorders, photodermatoses, vitiligo from radiotherapy and chronic or recurrent herpes simplex labialis.

07.02.01 Vaginal moisturisers 

Replens MD, Yes, Sylk - refer to Drug Tariff for products prescribable on FP10

05.03.02.01 Valaciclovir 

Second line. Use in secondary care restricted to GUM and Haematology

05.03.02.02 Valganciclovir Valcyte®

For CMV treatment only

04.02.03 Valproic Acid Depakote®
02.05.05.02 Valsartan 

Cardiology only post-MI for patients intolerant of ACEI strictly in accordance with MI pathway

05.01.07 Vancomycin Capsules

C. difficle treatment

05.01.07 Vancomycin 
11.03.01 Vancomycin intravitreal injection 

Unlicensed

04.10.02 Varenicline Champix®

Option for adults as part of smoking cessation programme

14.04 Varicella Zoster vaccine Zostavax®

National programme for adults aged 70

14.05.02 Varicella-Zoster immunoglobulin 
06.05.02 Vasopressin (argipressin) 

Secondary Care only

15.01.05 Vecuronium bromide Norcuron®
01.05.03 Vedolizumab Entyvio®

Moderately to severely active ulcerative colitis NICE TA 342, moderately to severely active Crohns disease NICE TA 352

08.01.05 Vemurafenib Zelboraf®
08.01.05 Venetoclax  

In line with NICE TA487  

04.03.04 Venlafaxine 

Only after adequate trial of two alternative antidepressants.  Not for patients with heart disease, including hypertension.  Refer to mental health provider guidelines.

 

Prescribe as immediate release if possible.  Most cost effective brand for modified release in primary care is Vensir XL Capsules

02.06.02 Verapamil 
02.06.02 Verapamil Hydrochloride Securon® SR
02.06.02 Verapamil Hydrochloride Half Securon® SR
02.06.02 Verapamil Hydrochloride Univer®
11.08.02 Verteporfin Visudyne®
04.08.01 Vigabatrin Sabril®

Refractory epilepsy only.  Includes tablets and sachets.

 

MHRA advice on switching:

 

Category 3: usually unnecessary to ensure that patients are maintained on a specific manufacturer's product unless there are specific concerns, such as patient anxiety and risk of confusion or dosing errors

08.01.04 Vinblastine Sulphate 
08.01.04 Vincristine Sulphate 
08.01.04 Vindesine Sulphate Eldisine®
08.01.04 Vinorelbine 
08.01.04 Vinorelbine Navelbine®
09.06.07 Vitamin and mineral supplements Forceval Soluble®

Only for patients with swallowing difficulties or being tube fed and who need a multivitamin and mineral supplement on advice from a dietician.

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

 

09.06.07 Vitamin and mineral supplements Ketovite®

Only on advice from dietetics

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

 

09.06.02 Vitamin B complex  Vigranon B®

NHS blacklisted - not to be prescribed on FP10.

09.06.02 Vitamin B Tablets, Compound Strong 

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

Malnutrition including alcoholism.

09.06.01 Vitamins A and D 

Vitamin A 4000 units, vitamin D 400 units (10 micrograms) per capusle.


May be difficult to obtain.

09.06.07 Vitamins capsules 

NHS England low value medication

For medically diagnosed eficiency, including for those patients who may have a lifelong or chronic condition or have undergone surgery which results in malabsorption.

A2.05.02 Vitaquick®  
03.01.05 Volumatic® 
05.02 Voriconazole Vfend®
04.03.03 Vortioxetine Brintellix®

Major depressive episodes in adults NICE TA 367

02.08.02 Warfarin 
02.08.02 Warfarin 5mg in 5ml 

Paediatrics only

09.02.02.01 Water for Injection 
06.01.06 Wavesense Jazz® 

Category 1 preferred

13.02.01 White Soft Paraffin BP 
11.08.01 White soft paraffin/liquid paraffin eye ointment VitA-Pos®, Lacri-Lube®

NHS England low value medication

A prescription for treatment of dry or sore eyes should not routinely be offered in primary care as the condition is appropriate for self-care.

12.02.02 Xylometazoline nasal drops Otrivine®

NHS England low value medicine

A prescription for coughs, colds and nasal congestion should not routinely be offered in primary care as the condition is self-limiting and will clear up on its own without the need for treatment.

14.04 Yellow fever vaccine (Live) 

Designated centres only

13.02.01 Yellow Soft Paraffin BP 
05.03.04 Zanamivir inhalation Relenza®
05.03.04 Zanamivir Injection 

Refer to PHT Microguide

13.02.01 Zerobase® 

Lower cost alternative to Diprobase

13.02.01 Zerocream® 

Lower cost alternative to E45 cream

13.02.01 Zerodouble® Gel  

Lower cost alternative to Doublebase ge

13.02.01 Zeroguent® 

Lower cost alternative to Unguentum M

13.02.01 Zeroveen®  

Lower cost alternative to Aveeno cream

19.11 Zetuvit E Sterile 10cm x 10cm 

Absorbent and protective. Used as a secondary dressing. NB Community nurses can obtain Surgipads from central stores.

19.11 Zetuvit E Sterile 10cm x 20cm 

Absorbent and protective. Used as a secondary dressing. NB Community nurses can obtain Surgipads from central stores.

19.11 Zetuvit E Sterile 20cm x 20cm 

Absorbent and protective. Used as a secondary dressing. NB Community nurses can obtain Surgipads from central stores.

19.11 Zetuvit E Sterile 20cm x 40cm 

Absorbent and protective. Used as a secondary dressing. NB Community nurses can obtain Surgipads from central stores.

05.03.01 Zidovudine Retrovir®

HIV infection only

05.03.01 Zidovudine and Lamivudine 

HIV infection only

13.02.02 Zinc and Caster Oil Ointment BP 
13.05.01 Zinc oxide 15% w/w and ichthammol 1% w/w in YSP 

Unlicensed special on BAD list and in Drug Tariff

 

 

09.05.04 Zinc Sulphate Solvazinc®
06.06.02 Zoledronic Acid 

Annual infusion for osteoporosis


Paget's disease

06.06.02 Zoledronic Acid 

Oncology only  - for symptomatic skeletal events in hormone-refractory prostate cancer.


Oncology only  - for adjuvant treatment of post-menopausal breast cancer (off-licence)


Palliative care

04.07.04.01 Zolmitriptan 

If orodispersible tablets are required prescribe 2.5mg strength

04.01.01 Zolpidem 

Short term use only

04.08.01 Zonisamide Zonegran®

Oral suspension 2mg in 1ml (unlicensed) - paediatrics only

 

MHRA advice on switching:

 

Category 2 - need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history.

04.01.01 Zopiclone 

Short term use only

04.02.01 Zuclopenthixol Clopixol®
04.02.01 Zuclopenthixol Acetate Clopixol Acuphase®

Psychiatry only

04.02.02 Zuclopenthixol Decanoate Clopixol®

Psychiatry only

04.02.02 Zuclopenthixol Decanoate Clopixol® Conc.

Psychiatry only

Portsmouth and South East Hampshire